細胞別網羅的解析に基づくニチニチソウ二次代謝機構の解明 by 山本, 浩太郎
 Kobe University Repository : Thesis  
学位論文題目
Tit le
Cell-specific analysis of specialized metabolism in Catharanthus
roseus(細胞別網羅的解析に基づくニチニチソウ二次代謝機構の解明)
氏名
Author 山本, 浩太郎
専攻分野
Degree 博士（理学）
学位授与の日付
Date of Degree 2017-03-25
公開日
Date of Publicat ion 2019-03-25
資源タイプ
Resource Type Thesis or Dissertat ion / 学位論文
報告番号
Report  Number 甲第6858号
権利
Rights
JaLCDOI
URL http://www.lib.kobe-u.ac.jp/handle_kernel/D1006858
※当コンテンツは神戸大学の学術成果です。無断複製・不正使用等を禁じます。著作権法で認められている範囲内で、適切にご利用ください。
PDF issue: 2019-04-18
 
 
博士論文 
Cell-specific analysis of specialized metabolism  
in Catharanthus roseus 
細胞別網羅的解析に基づく  
ニチニチソウ二次代謝機構の解明  
 
 
 
 
 
 
 
 
 
 
 
平成 29 年 1 月  
神戸大学大学院理学研究科 
山本	 浩太郎 
 
  
Table of contents 
1. Abstract       …1 
2. Abbreviation       …3 
3. General introduction : Alkaloids biosynthesis in plants   …6 
4. Chapter 1 : Cell-specific TIA localization in Catharanthus roseus stem tissue
        …12 
5. Chapter 2 : Cell-specific TIA localization in Catharanthus roseus leaf tissue
        …52 
6. Chapter 3 : Molecular analyses of idioblast cells and laticifer cells in Catharanthus 
roseus       …80 
7. General discussion and concluding remarks : TIA biosynthesis mechanism in 
Catharanthus roseus plant      …115 
8. References                                                   …123 
9. Acknowledgments      …131 
 
 
 1 
Abstract 
Cell-specific analysis of specialized metabolism in Catharanthus roseus 
細胞別網羅的解析に基づくニチニチソウ二次代謝機構の解明  
 
理学研究科	 山本浩太郎 
 
	 植物は、昆虫や草食動物などの捕食者に対する防御物質として、カフェイン
やモルヒネのような二次代謝産物を生産している。これらの二次代謝産物の中
には、人に有用な物質が数多くあり、植物の二次代謝機構を研究することは、
有用二次代謝産物の効率的生産法の開発にも繋がる。 
	 ニチニチソウ（Catharanthus roseus）は、Vinblastine や Vincristine などの抗が
ん剤となる Terpenoid indole alkaloid（TIA）をはじめとして、様々な二次代謝産
物を生合成することで著名な薬用植物である。ニチニチソウの TIA 合成は、一
連の生合成過程が茎や葉組織において葉肉細胞、表皮細胞など様々な細胞を経
由して進むことが、遺伝子発現解析などに基づいて報告されている。特に
Idioblast cell（異形細胞）や Laticifer cell（乳管細胞）が TIA 代謝の重要な過程に
関与すると考えられてきたが、これらの細胞内や細胞間における二次代謝過程
の分子機構は十分には理解されていない。 
	 私は、ニチニチソウ茎組織や葉組織における細胞レベルでのアルカロイドの
分布から TIA 代謝メカニズムを解明しようと考え、一細胞質量分析技術や質量
顕微鏡を用いた細胞別メタボローム解析を試みた。その結果、Vindoline や
Serpentine などの Idioblast cell や Laticifer cell で合成されると推測される TIA は
もとより、これまで表皮細胞で合成されると考えられてきた Strictosidine などの
TIAも Idioblast cellやLaticifer cellに多く蓄積されていることが明らかになった。
既知の代謝経路と代謝物の分布との間に矛盾が見られることから、植物内での
TIA 物質の合成、移動、分布・蓄積を制御する未知のメカニズムが存在する可
能性が示唆される。さらに、茎組織と葉組織の細胞レベルでの比較メタボロー
ム解析より、組織特異的な Idioblast cell や Laticifer cell の TIA 代謝分化が起きて
いる可能性が示唆された。これらの違いを解明するために、Idioblast cell や
Laticifer cell を単離することや、細胞特異的なトランスクリプトーム解析を試み、
Idioblast cell で特異的に発現する複数の二次代謝合成酵素やトランスポーターの
候補を得ることに成功した。 
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Fig. 1. TIA biosynthesis in Catharanthus roseus stem and leaf tissues. Green font represents the 
TIA enzyme localized in internal phloem associated parenchyma (IPAP) cells. Purple represents 
TIA enzyme localized in epidermal cells. Blue represents TIA enzyme localized in idioblast 
cells and laticifer cells. Inset is a fluorescent photograph of leaf cross section. Scale bar = 100 
µm.  
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Abbreviation 
BIA : Benzylisoquinoline alkaloid 
C. roseus : Catharanthus roseus 
FPKM : Fragments per kilobase of transcript per million mapped reads 
FSC : Forward scatter 
FW : Fresh weight 
IPP : Isopentenyl diphosphate 
LC-MS : Liquid chromatography mass spectrometry 
MS : Mass spectrometry 
PCA : Principal component analysis 
SSC : Side scatter 
TIA : Terpenoid indole alkaloid 
UV : Ultraviolet 
 
Abbreviation (Enzyme) 
10HGO : 10-Hydroxygeraniol oxidoreductase 
16OMT : 16-Hydroxytabersonine O-methyltransferase 
7DLH : 7-Deoxyloganic acid 7-hydroxylase 
D4H : Desacetoxyvindoline 4-hydroxylase 
DAT : Deacetylvindoline 4-Oacetyltransferas 
DLGT : 7-Deoxyloganetic acid glucosyltransferase 
G10H : Geraniol 10-hydroxylase 
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GES : Geraniol synthase 
IS : Iridoid synthase 
LAMT : Loganic acid O-methyltransferase 
NMT : 16-Methoxy-2,3-dihydro-3-hydroxy-tabersonine N-methyltransferase 
SGD : Strictosidine β-glucosidase 
SLS : Secologanin synthase 
STR : Strictosidine synthase 
T16H : Tabersonine 16-hydroxylase 
T3O : Tabersonine 3-oxygenase 
T3R : Tabersonine 3-reductase 
TDC : Tryptophan decarboxylase 
 
Abbreviation in figures and tables (Cell) 
EC : Epidermal cell 
IC : Idioblast cell 
IPAP : Internal phloem associated parenchyma 
LC : Laticifer cell 
LEC : Leaf epidermal cell 
LLC : Leaf laticifer cell 
LPLC : Leaf primordium laticifer cell 
PC : Parenchyma cell 
PTIC : Palisade tissue idioblast cell 
 5 
PTPC : Palisade tissue parenchyma cell 
STIC : Spongy tissue idioblast cell 
STPC : Spongy tissue parenchyma cell 
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General introduction : 
Alkaloids biosynthesis in plants 
 
Many alkaloids are produced in plants. 
Plants produce various kinds of specialized metabolites which have been formerly 
called as secondary metabolites. Those specialized metabolites have biological activities 
to support the life of plants. They are functioning to defend against predators like 
insects and herbivores, to guard against UV radiation or to attract pollinators.  
 Plant specialized metabolites are indispensable not only for plants themselves 
but also for human welfare. The significant values of specialized metabolites as 
medicines or luxury items in human life have been attracting widespread interests from 
researchers in a broad range of scientific fields. These researchers have extensively 
studied how specialized metabolites are produced at biochemical, cell and tissue levels 
in each plant (Kutchan, 2005). 
Plant specialized metabolites are classified into three major categories, such 
as terpenoids, flavonoids and alkaloids, on the basis of their chemical structures. 
Alkaloids contain nitrogen in their molecular forms. About 20% of plant species are 
known to contain alkaloids (De Luca, 2011). It has been reported that certain 
biosynthetic pathways of plant specialized metabolites, including alkaloids synthesis, 
often involve multiple cell types that are biochemically and morphologically distinct 
(Hagel et al., 2008; Pan et al., 2016). Thus far, there is no answer about a question “why 
and how their specialized metabolisms are progressed across various different kinds of 
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cells ? “.  
Alkaloids producing pathways have been studied well for their 
pharmaceutical and biological properties. Opium poppy is one of the famous medicinal 
plants producing morphine and codeine. This plant has been used as a model system to 
investigate benzylisoquinoline alkaloids (BIA) biosynthesis in plants (Beaudoin et al., 
2014). At least 3 distinct cell types, such as companion cells, sieve elements and 
laticifer cells, are involved in the biosynthesis and storage of BIA in opium poppy. It 
has been suggested that the end product, such as morphine, is synthesized and 
accumulated in laticifer cells (Beaudoin et al., 2014). Since these BIAs have biological 
activities, the laticifer cells in opium poppy might be afforded to sequester toxic 
alkaloids and pathway intermediates from other BIA-sensitive cells (Facchini et al., 
2005). However, the relations between each type of cell and specialized metabolism 
have been mostly unknown, yet. This is the same in other plants even certain famous 
plants producing specialized metabolites. In the present study, in order to reveal the 
relationship between cell-specific specialized metabolism and unique differentiating 
cells (such as idioblast cells or laticifer cells), I have focused on investigating indole 
alkaloid metabolism at cell levels in Catharanthus roseus (L.) G. Don. 
 
Alkaloids biosynthesis in Catharanthus roseus (L.) G. Don. 
Terpenoid indole alkaloids (TIA) classified as a kind of alkaloids are synthesized in 
Apocynaceae, Rubiaceae and Loganiaceae (Balsevich et al., 1988). TIA biosynthesis 
involves the assembly of tryptamine, which is produced from L-tryptophan, with a 
 9 
secologanin. Catharanthus roseus (L.) G. Don (Apocynaceae) is one of the 
best-characterized TIA producing plants. This plant can produce many commercially 
valuable TIAs, including antitumor drugs such as vinblastine and vincristine. That is 
one of reasons why specialized metabolisms in this plant have been studied well. These 
researches revealed that this plant has many sub TIA metabolic pathways (Fig. 1). Since 
the finding and development of TIAs as antitumor drugs in the 1970s, leaf extracts of C. 
roseus have been the sole source of vindoline and catharanthine, both of which are 
monomeric precursors for the commercial production of TIA (O’Keefe et al., 1997). 
Extensive studies have revealed that more than 130 TIAs are produced from the central 
precursor (i.e. strictosidine) in C. roseus (Fig. 1) (Verma et al., 2012).  
The TIA biosynthetic pathway in C. roseus consists of many sub-pathways, 
including iridoid pathway, serpentine pathway, catharanthine pathway and vindoline 
pathway. It is believed that most TIAs are also produced thorough various cell types and 
organelles in C. roseus from the results based on the localization of TIA and iridoid 
biosynthesis enzymes by in situ hybridization, immunoblot or transcriptomic analysis 
(Van Der Heijden et al., 2004; Gigant et al., 2005; Kavallaris, 2010). Recently, the 
entire iridoid pathway, from geranyl diphosphate to secologanin, in C. roseus has been 
biochemically and genetically elucidated (Fig. 1). It is suggested that most of this 
pathway are proceeding in internal phloem associated parenchyma cell (IPAP cell). 
Loganic acid produced in the IPAP cell is transported to epidermal cell where this 
iridoid is converted to secologanin. Subsequent strictosidine biosynthesis is conducted 
by strictosidine synthase (STR) in vacuoles of epidermal cells. Then, strictosidine 
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β-glucosidase (SGD) acts in the cleavage of strictosidine in nucleus to produce aglycone 
precursors required for various chemical skeletons, such as corynanthe type (serpentine 
pathway), aspidosperma type (vindoline pathway, vindorosine (demethoxyvindoline) 
pathway) and iboga type (catharanthine pathway) (Figs. 1 and 2) (Qu et al., 2015).  
Although serpentine and catharanthine pathway have still been most unknown, 
the vindoline pathway have been studied well and characterized from tabersonine to 
vindoline or to vindorosine (Qu et al., 2015). It is believed that most TIA intermediates 
of these pathways are converted within the epidermal cells. TIA products of last 2-steps 
in vindoline pathway (deacetylvindoline and vindoline) are produced in both idioblast 
cells and laticifer cells (Fig. 1). It has been considered that these TIA end products are 
finally accumulated in the vacuoles of idioblast cells or laticifer cells. 
These days, immunoblot and GFP-fusion analyses also revealed which 
organelle is localizing TIA enzymes in C. roseus cells. MEP pathway started from 
plastid in IPAP cells and produces geraniol there (Verma et al., 2012; Pan et al., 2016). 
It is believed that loganic acid is produced from geraniol in ER or the cytosol in IPAP 
cells. Secologanin is produced in the cytosol or ER in epidermal cells and transported 
into the vacuole to produce strictosidine. Then β-glucosidase produces strictosidine 
aglycone from strictosidine in the nucleus in epidermal cells. It is believed that 
subsequent TIA metabolisms are conducted among various organelles in epidermal cells. 
Desacetoxyvindoline is transported from epidermal cells to idioblast cells and laticifer 
cells and this TIA is converted to vindoline in the cytosol in idioblast cells and laticifer 
cells finally. Then vindoline is accumulated into the vacuoles in idioblast cells and 
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laticifer cells.  
At present, it has still been mostly unknown how metabolites are transported 
between cells or organelles and how the expression of TIA-relating genes in idioblast 
cells and laticifer cells are regulated.  
In the present study, I aimed to clarify TIA biosynthetic mechanism at cellular 
levels in stem and leaf tissues in C. roseus. At Chapter 1, I tried to reveal the 
cell-specific localization of TIA intermediates in C. roseus stem tissue. At Chapter 2, I 
also attempted to measure the cell-specific localization of TIA intermediates in C. 
roseus leaf tissue. In both cases, I used cutting-edge metabolome techniques, that is, 
Imaging MS and Single-cell MS. From these analyses, I found that the idioblast cells 
and laticifer cells are playing key roles in the specialized metabolism in this plant. At 
Chapter 3, I focused on the molecular mechanisms of the specialized metabolism of 
these cells by conducting cell-specific transcriptome analysis. 
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Chapter 1 :  
TIA localization in C. roseus stem tissue 
 
Summary 
Catharanthus roseus (L.) G. Don is a medicinal plant well known for producing 
antitumor drugs such as vinblastine and vincristine, which are classified as terpenoid 
indole alkaloids (TIAs). The TIA metabolic pathway in C. roseus has been extensively 
studied. However, the localization of TIA intermediates at the cellular level has not 
been demonstrated directly. In this chapter, the metabolic pathway of TIA in C. roseus 
was studied with two forefront metabolomic techniques (i.e. Imaging MS and live 
Single-cell MS) to elucidate cell-specific TIA localization in the stem tissue. Imaging 
MS indicated that most TIAs localize in the idioblast cells and laticifer cells, which emit 
blue fluorescence under UV excitation. Single-cell MS was applied to four different 
kinds of cells [idioblast (specialized parenchyma cell), laticifer, parenchyma and 
epidermal cells] in the stem longitudinal section. Principal component analysis of 
Imaging MS and Single-cell MS spectra of these cells showed that similar alkaloids 
accumulate in both idioblast cells and laticifer cells. From MS/MS analysis of 
Single-cell MS spectra, catharanthine, ajmalicine and strictosidine were found in both 
cell types in C. roseus stem tissue. Serpentine was also accumulated in the same cells. 
Based on these data, I discuss the significance of TIA synthesis and accumulation in the 
idioblast cells and laticifer cells of C. roseus stem tissue. 
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Introduction 
Alkaloids constitute one of the largest groups of specialized metabolites, many of which 
have biological functions that are indispensable, not only for plants themselves but also 
for human health. Approximately 20% of plant species are known to contain alkaloids 
(De Luca, 2011). Catharanthus roseus (L.) G. Don (Apocynaceae) is one of the 
best-characterized terpenoid indole alkaloid (TIA) producing plants. This plant 
produces many commercially valuable TIAs, including antitumor drugs such as 
vinblastine and vincristine (Van Der Heijden et al., 2004; Gigant et al., 2005; Kavallaris, 
2010). 
 TIA metabolism in C. roseus involves more than 20 enzymatic steps and 
occurs in various cell types, starting from internal phloem associated parenchyma cells 
(IPAP cells) through epidermal cells (ECs) to both idioblast cells (ICs) and laticifer 
cells (LCs) where vindoline and other TIAs are believed to be accumulated (Yoder et al., 
1976; Mahroug et al., 2006; Dugé de Bernonville et al., 2015). Cell type-specific 
localization of TIA metabolic pathways has been primarily inferred indirectly from the 
results of in situ RNA hybridization and immunocytochemical localization of the 
pathway enzymes (St-Pierre et al., 1999). The current understanding, mainly deduced 
from studies on leaf tissue, is that iridoid metabolism begins in IPAP cells and that 
loganic acid produced in IPAP cells is transferred to epidermal cells. Further synthesis 
involving secologanin and tryptamine occurs in the epidermal cells. Finally, a TIA 
intermediate, desacetoxyvindoline, moves to the idioblast cells and laticifer cells, and 
TIAs are accumulated in the vacuole of those cells (Yoder et al., 1976; Burlat et al., 
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2004; Dugé de Bernonville et al., 2015). In the stem, a similar localization of enzymes 
in TIA metabolism (TDC, tryptophan decarboxylase; STR, strictosidine synthase; D4H, 
desacetoxyvindoline 4-hydroxylase; and DAT, deacetylvindoline 4-O-acetyltransferase 
in Fig. 1) has been proposed (St-Pierre et al., 1999). Thus far, however, the actual 
localization of TIA intermediates at the cellular level has not been directly measured in 
either leaf or stem tissues. 
Recently, similar specialized metabolite biosynthetic pathways have been 
reported in other plants at the cellular level. For example, polyterpenes are highly 
accumulated in so-called laticifer cells in rubber trees (Hevea brasiliensis), and enzymes 
that are responsible for polyterpene biosynthesis have been identified (Hagel et al., 
2008). Likewise, a benzylisoquinoline alkaloid morphine is accumulated in laticifer 
cells in opium poppy (Papaver somniferum). In both cases, cutting the laticifer cells 
located in the stem of rubber trees or seed capsule in opium poppy permits the 
collection of these valuable plant metabolites. Moreover, proteome analysis of opium 
poppy shows that enzymes for morphine biosynthesis are localized either in sieve 
elements or laticifer cells (Bird et al., 2003; Lee et al., 2013; Onoyovwe et al., 2013). 
These results suggest that the metabolic intermediates in morphine biosynthesis are 
likely to be shuttled between the two cell types of sieve elements and laticifer cells, and 
that laticifer cells are metabolically active (Onoyovwe et al., 2013). To understand in 
detail the metabolic pathways, however, identification of not only the localization of the 
enzymes but also the localization of these specialized metabolites themselves at the 
cellular level is necessary. 
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Novel methods for detecting metabolites in situ at the cellular level have been 
developed. Examples include matrix-assisted laser desorption/ionization imaging mass 
spectrometry (Imaging MS), which was applied to animal brain sections (Stoeckli et al., 
2001), and desorption electrospray ionization mass spectrometry, which has been 
applied to many plant species, including C. roseus (Hemalatha et al., 2013) and 
Hypericum perforatum (Thunig et al., 2011). These studies succeeded in detecting 
target metabolites, but the resolution of the mass image was very low. Recent imaging 
MS revealed localization of many secondary metabolites in the rhizome of Glycyrrhiza 
glabra, with high resolution of about 20 µm (Li et al., 2014). The localization of 
metabolites at the cellular level of Arabidopsis tissues is also reported (Takahashi et al., 
2015). 
Another option for analyzing metabolite localization at the cellular level is 
Single-cell MS, which identifies cell contents from a single cell collected by using 
microcapillaries (Mizuno et al., 2008). In the Geraniaceae, Pelargonium zonale (L.) 
L’Herit, the metabolites from a single cell were measured by video-assisted MS and 
revealed differences between metabolite contents among cells in different tissues 
(Lorenzo Tejedor et al., 2012). 
Stem tissue consists of various cell types that are similar to those in leaf tissue, 
and in situ RNA hybridization of genes for enzymes involved in TIA metabolism in 
stems has also been reported (St-Pierre et al., 1999). In the present study, I combined 
the above two forefront metabolomic techniques, Imaging MS and Single-cell MS, to 
elucidate cell-specific TIA localization in Catharanthus stem tissue.  
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Result 
Localization of idioblast cells and laticifer cells in C. roseus stem tissue.  
C. roseus stem tissue is composed of various types of cells : idioblast cell, laticifer cell, 
parenchyma cell (PC) and epidermal cell. Idioblast cell and laticifer cell were easily 
distinguishable from parenchyma cell and epidermal cell by blue or yellow 
autofluorescence emitted from the chemical compounds accumulated in these cells, 
when the specimen was excited by UV (Mersey et al., 1986). The blue autofluorescence 
occurs most likely from serpentine (Hisiger et al., 2005). In longitudinal sections, 
idioblast cells were found throughout the stem tissue, whereas short and elongated 
laticifer cells localized near the vascular bundles (Figs. 3L and 4). 
 
TIAs in stem tissue.  
Liquid chromatography mass spectrometry (LC-MS) analysis of the extracts from 
whole stem tissue identified mass spectral peaks of various TIAs, including 
catharanthine, ajmalicine, serpentine and vindoline (Table 1). Loganic acid, loganin, 
and secologanin were also detected (Table 2). Some of the peaks were subjected to 
MS/MS or LC-MS/MS analyses for further confirmation (Figs. 5-9 and Table 3), and 
quantitative data were obtained for the main alkaloids in the extracts from both stem 
tissue and the first leaf tissue (Table 1). In stem tissue, the concentrations were [µg mg-1 
fresh weight (FW)] catharanthine, 0.506 ± 0.044; ajmalicine, 0.071 ± 0.022; serpentine, 
0.397 ± 0.031; tabersonine, 0.017 ± 0.003; and vindoline, 0.0026 ± 0.0002. 
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Imaging MS analysis.  
To study the localization of TIA in the whole stem tissue, I conducted Imaging MS 
analysis using a longitudinal section of C. roseus stem tissue (Fig. 3). The results 
showed that monoterpenes, such as loganin (Fig. 3B) and secologanin (Fig. 3C), were 
localized in epidermal cell as reported previously (Guirimand et al., 2011). 
Although it has been proposed from in situ RNA hybridization experiments 
that most TIAs are synthesized in epidermal cell (St-Pierre et al., 1999), MS images 
revealed that various TIAs, including ajmalicine and serpentine, were accumulated not 
in epidermal cell but rather in idioblast cell and laticifer cell (Fig. 3D-J). An MS image 
of m/z 337.19 (a possible candidate is catharanthine; see Fig. 3I) showed that this 
compound was localized in idioblast cell, laticifer cell and epidermal cell. 
The mass spectrum data of four cell types (idioblast cell, laticifer cell, 
parenchyma cell and epidermal cell) were selected from Imaging MS figures and 
analyzed by principal component analysis (PCA). The various cell types could be 
distinguished as different groups. The PCA result showed that idioblast cell and laticifer 
cell accumulated similar compounds, which differed from those in parenchyma cell and 
epidermal cell (Fig. 10A). Loading data for PCA are shown in Fig. 10B. 
 
Single-cell MS analysis.  
To obtain quantitative data of various TIAs that complement the results of Imaging MS, 
I conducted Single-cell MS on idioblast cell, laticifer cell, parenchyma cell and 
epidermal cell (Fig. 4). The data obtained from the four cell types could also separate 
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the cells into different groups by PCA. The PCA result showed that idioblast cell and 
laticifer cell accumulated similar compounds, which differed from those in parenchyma 
cell and epidermal cell, in agreement with the data from Imaging MS (Fig. 10). I also 
obtained PC loading data that suggested some alkaloid peaks, such as m/z 337.19 
(catharanthine) and m/z 349.15 (serpentine), mainly occur in specific cell types (Fig. 
10C and D). 
I conducted target mass analysis of C. roseus TIA using Single-cell MS data 
(Tables 4 and 5). The mass spectra of idioblast cell and laticifer cell showed that 
catharanthine (m/z 337.19) and serpentine (m/z 349.15) were detected in the top 100 
peaks in those spectra. Catharanthine (m/z 337.19) was also detected in the mass spectra 
of parenchyma cell and epidermal cell. 
I examined MS/MS analyses of a peak having m/z 337.19 to clarify whether 
this was mainly catharanthine or tabersonine (Figs. 5 and 11). As a result of MS/MS, I 
detected a catharanthine-specific fragment peak (m/z 93.07) from all types of cells 
(Table 4 and Figs. 5 and 11), although the peak intensity in parenchyma cell and 
epidermal cell was low. Other catharanthine-specific peak was not detected in 
parenchyma cell (m/z 133.07). 
The MS/MS analysis strongly suggested that the peak having the m/z 337.19 
that localized in idioblast cell and laticifer cell and the whole stem tissue is 
catharanthine. MS/MS fragments corresponding to serpentine (m/z 349.15) and 
ajmalicine (m/z 353.18) were also detected in Single-cell MS and LC-MS/MS analyses 
(Table 3 and Figs. 6 and 7). I also speculated on the possible TIA identities of several 
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other peaks (Table 1). To determine whether these peaks were really TIA, I examined 
their MS/MS fragments. In m/z 427.22 peak, which is supposed to be 
demethoxyvindoline, the major MS/MS fragments had m/z of 158.10, 367.20, and 
409.21 (Fig. 8). These peaks are similar to the vindoline MS/MS fragment pattern (m/z 
188.10, 397.20, and 439.21), although demethoxyvindoline MS/MS fragments may 
alter by m/z 30 owing to the deletion of the methoxy group and addition of a proton. At 
m/z 531.23 ion peak, detected fragment ion peaks (m/z 144.08, 165.05, 282.11, 320.13, 
334.14, 352.16, and 514.21) were similar to the major MS/MS fragments of 
strictosidine that was produced by transformed yeast (Table 3) (Brown et al., 2015). 
 
Semiquantitative analysis of Single-cell MS.  
The metabolome of C. roseus stem tissues was analyzed using LC-MS. Single peaks at 
m/z 349.15, 427.22, and 531.23 correspond to serpentine, demethoxyvindoline and 
strictosidine, respectively (Table 1). According to the LC-MS result, I can consider that 
these m/z values show a single molecular species in each cell type of C. roseus stem 
tissue. Semiquantitative calculations were made in regard to m/z 349.15, 389.14, 427.22, 
and 531.23 ion peaks from the Single-cell MS data measured with mass range m/z = 
100-1,000 (Fig. 12A and B) and mass range m/z = 385-550 (Fig. 12C and D). 
Serpentine (m/z 349.15) was detected in both idioblast cell and laticifer cell (Fig. 12A), 
whereas secologanin (m/z 389.14) was only accumulated in epidermal cell (Fig. 12B). 
Demethoxyvindoline (m/z 427.22) was detected in every type of cell, but with large 
variations; it was mainly accumulated in idioblast cell and laticifer cell (Fig. 12C). 
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Strictosidine (m/z 531.23) was also accumulated in idioblast cell and laticifer cell (Fig. 
12D).  
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Discussion 
TIA synthesis in the stem tissue C. roseus var. Equator White Eye.  
LC-MS data of C. roseus stem extracts showed major peaks from TIAs, including 
catharanthine and vindoline (Table 1). These data suggest that the variety Equator 
White Eye also produces major TIAs in stem tissue; previous reports on other C. roseus 
varieties have focused on TIA in leaf tissue (Murata et al., 2005). I could not detect all 
of the vindoline-related intermediates in Single-cell MS data of this variety, even 
though I succeeded in detecting vindoline and demethoxyvindoline (Tables 4 and 5). It 
is known that C. roseus stem tissue produces less vindoline than leaf tissue (Singh et al., 
2008). The present LC-MS quantitative data showed also that the first pair of leaves 
accumulated more vindoline than stem tissue (Table 1). 
 
Identification of TIA peaks.  
Many peaks corresponding to TIAs were detected using these recent metabolome 
techniques (i.e. Imaging MS and Single-cell MS). Both of these mass spectrometry 
systems have quite high mass resolution and high mass accuracy. Values of m/z 
suggested elemental compositions that could be tentatively assigned to TIAs based on 
their molecular formulae. To verify that these peaks were TIAs, I measured chemical 
structures of commercially available TIAs by MS/MS analysis using the same MS 
apparatus (Table 3 and Figs. 5-9). I was able to confirm, using standard MS/MS 
fragment data, that idioblast cell and laticifer cell contain catharanthine, serpentine and 
ajmalicine.  
 23 
Cell-specific localization of TIAs in C. roseus stem tissue.  
Imaging MS data showed that loganin and secologanin localized in the epidermal cell 
(Fig. 3). Single-cell MS showed the same localization for secologanin (Fig. 12). These 
iridoid metabolites have previously been shown to be synthesized in epidermal cell in C. 
roseus stem tissue (Dugé de Bernonville et al., 2015), and this has been confirmed using 
my metabolome analyses, too. 
I was not able to ionize loganic acid and loganin in Single-cell MS. Although 
I could not semiquantify these substances, but I assumed that loganic acid was localized 
in IPAP cells from Imaging MS observation (Fig. 3A). 
Imaging MS and Single-cell MS data also showed that most TIAs, including 
catharanthine (m/z 337.19), were localized in idioblast cell and laticifer cell (Table 4 
and Figs. 3 and 13). These data contrast with previously published reports that showed 
most catharanthine localized in the wax layer of the leaf tissue (Roepke et al., 2010; Yu 
et al., 2013). The reasons for these differences are unclear but may reflect differences 
between cultivars or differences between stem and leaf tissue. The stem tissue has no 
clear wax layer. I do not detect substances in the wax layer. 
When I measured extracts of both tissues with LC-MS, leaf tissue was found 
to contain more TIA metabolites than stem tissue (Table 1), which Góngora-Castillo et 
al. (2012) attributed to differences in expression levels of genes involved in TIA 
biosynthesis between stem and leaf tissues. 
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TIA synthesis and accumulation in C. roseus idioblast cells and laticifer cells.  
It has been proposed that TIA synthesis initially occurs in IPAP cell, and then the 
products shift from IPAP cell to epidermal cell, parenchyma cell, idioblast cell and 
laticifer cell. It is proposed that loganic acid is transferred from IPAP cell to epidermal 
cell and 16-methoxytabersonine is transferred from epidermal cell to other cells at that 
time. This hypothesis is mainly based on in situ hybridization data of mRNAs of genes 
encoding enzymes involved in TIA synthesis (Dugé de Bernonville et al., 2015) rather 
than on the actual localization of TIA molecules themselves at the cellular level 
(Mersey et al., 1986). 
The chemical compounds contained in idioblast cell and laticifer cell have not 
previously been accurately measured. To identify TIA compounds accumulated in 
idioblast cells, I used the recent technologies of Imaging MS and Single-cell MS. My 
measurements showed that most alkaloids are localized in idioblast cell and laticifer cell 
(Tables 4 and 5). These data are consistent with a previous report, which showed that 
serpentine, ajmalicine and vindoline accumulated in the idioblast fraction (Mersey et al., 
1986), although the purity of their idioblast fraction was quite low. To our surprise, the 
present metabolome results showed that strictosidine also localized in idioblast cell and 
laticifer cell (Tables 4 and 5). Strictosidine might move from epidermal cell to idioblast 
cell and laticifer cell as soon as it is produced. 
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Movement of TIA intermediates between cells.  
Imaging MS and Single-cell MS results revealed that many TIAs are localized in 
idioblast cell and laticifer cell. Catharanthine, whose presence was inferred from m/z 
337.19, was detected in all types of cells. TIA intermediates, such as strictosidine, 
catharanthine and tabersonine, are proposed to be synthesized in epidermal cell, and 
further metabolism of these compounds occurs in the same cell (St-Pierre et al., 1999; 
Dugé de Bernonville et al., 2015). The present results lead to my presumption that 
catharanthine metabolism might not only occur in epidermal cell but may also be 
progressed in idioblast cell and laticifer cell. 
Imaging MS and Single-cell MS data showed that loganin and secologanin 
localized in the epidermal cell (Figs. 3 and 12). These iridoid metabolites have 
previously been shown to be synthesized in epidermal cell in C. roseus stem tissue 
(Dugé de Bernonville et al., 2015), and this has been also confirmed by using my 
metabolome analyses. 
Single-cell MS measurements suggested that TIA intermediates were 
accumulated in idioblast cell and laticifer cell (Fig. 12). If they are not synthesized in 
these cells, TIA intermediates must move from synthetic cells to other cells and 
accumulate in idioblast cell and laticifer cell. Because I could not detect an m/z value 
for strictosidine, which is produced by condensation of secologanin and tryptamine in 
epidermal cell, it is possible that strictosidine migrated to idioblast cell and laticifer cell 
immediately after synthesis. An m/z value corresponding to strictosidine (m/z 531.23) 
was detected in idioblast cell and laticifer cell, and I also obtained MS/MS fragment ion 
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peaks (m/z 144.08, 165.05, 282.11, 320.13, 334.14, 352.16, and 514.21), which are 
consistent with the speculated strictosidine MS/MS fragment ion peaks (Tables 3-5 and 
Fig. 9) (Brown et al., 2015). A compound peak at m/z 427.22 was detected in every type 
of cells (Tables 4 and 5). MS/MS fragment ions of this peak were similar to 
demethoxyvindoline (vindorosine) (Zhou et al., 2005), although I could not obtain a 
commercially available standard to verify this. I have tentatively assigned the m/z 
427.22 peak as demethoxyvindoline, which accumulated in idioblast cell and laticifer 
cell (Fig. 12).  
The complex distribution pattern of the TIA intermediates suggests that the 
enzymes responsible for synthesis are located in one cell type, but that the enzyme 
products are then moved to other cells. A catharanthine transporter responsible for 
efflux from epidermal cell to the wax layer in C. roseus leaf tissue has been already 
reported (Yu et al., 2013). It is also possible that symplasmic transport via 
plasmodesmata may drive movements of TIA intermediates between adjacent cells (Fig. 
13). Further studies are needed to clarify how these compounds become distributed 
between the different cell types. 
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Material and method 
Plant material and sample preparation.  
C. roseus (L.) G Don (cv. Equator White Eye) was grown at 25 °C under 14 light/10 
dark h white fluorescent light photoperiod in a growth chamber (NKsystem). Seeds 
were purchased from Sakata Seed Corporation. 
Stem tissue of C. roseus was harvested from about 3-month-old plants just 
before experiments. 
 
Observation of idioblast cells and laticifer cells with microscope.  
Bright field and epifluorescence microscopy were performed on a Leica M205FA 
microscope (Leica Microsystems). Ultraviolet long pass filter (ET UV LP, Leica 
Microsystems) was used as the epifluorescence filter for observation of idioblast cells 
and laticifer cells. 
 
Chemicals.  
Commercially available TIA standards, catharanthine (Enzo Life Sciences), tabersonine 
HCl (AvaChem Scientific), ajmalicine (AdipoGen), serpentine hydrogen tartrate 
(ChromaDex), vindoline (ChromaDex) and vindoline-d3 (Tronto Research Chemicals) 
were used. One-parts-per-million (ppm) solutions of these chemicals were used as 
standards in LC-MS/MS analysis and infusion analysis with LTQ Orbitrap (LTQ 
Orbitrap Velos Pro; Thermo Fisher Scientific) used for the Single-cell MS (MS/MS) 
analysis.  
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Extraction of TIAs from C. roseus tissues.  
C. roseus stem and leaf tissues were frozen with liquid nitrogen immediately after 
harvesting and ground to fine powder by frost shattering with Multibeads shocker 
(Yasui Kikai). Metabolites were extracted from the powdered sample with 1 mL 
extraction solution (0.5% formic acid and 1 ppm vindoline-d3 in methanol). Samples 
were lyophilized with a freeze-dryer (Model 77400; Labconco Co.) and stored at -80 °C 
until measurement. 
 
LC-MS analysis.  
Crude extracts of C. roseus stem and leaf tissues were analyzed by LC-MS 
(Prominence). The mobile phases A and B were 25 mM ammonium acetate and 
acetonitrile, respectively. The ratio of solvent A to B was isocratic at 20 : 80. TIAs were 
separated by reverse-phase octadecylsilyl (ODS) column (Eclipse XDB-C18, 5 µm, 
4.6×150 mm; Agilent). The flow rate was 0.25 mL min−1 at 40 °C. I used vindoline-d3 
as an internal standard for quantification of TIA intermediates. 
Mass spectrometric detection was performed on LTQ-Orbitrap (LTQ Orbitrap 
Velos Pro; Thermo Fisher Scientific) mounted on ESI ion source. The spray voltage for 
positive measurement was 3,800 V. Target mass peaks were detected in ± 5 ppm. 
 
Imaging MS.  
Longitudinal sections (100 µm thickness) of C. roseus stem were prepared with a 
microtome (Plant Microtome MTH-1; NKsystem) and visually inspected with a 
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fluorescent stereoscopic microscope (M250FA; Leica Microsystems). Suitable sections 
were then washed with MilliQ water to remove alkaloid contamination from dead cells 
and mounted on Indium Tin Oxide glass slides (Luminescence Technology Co.) using 
Cryoglue type I (SECTION-LAB Co. Ltd.). The samples on glass slides were 
lyophilized by freeze-drying (Model 77400; Labconco Co.) then sublimated by 
α-cyano-4-hydroxycinnamic acid with a conductive glass using a sublimation apparatus 
(ChemGlass CG-3038; ChemGlass Life Sciences). Mass spectrometric detection was 
performed on Fourier transform ion cyclotron resonance mass spectrometry 
(FT-ICRMS) (APEX-Qe 9.4T with dual source; Bruker Daltonics Inc.). The space 
resolution of Imaging MS was 20 µm. MS images were reconstituted using an in-house 
software called LabMSI (Takahashi et al., 2015). Target mass peaks were detected in a 
bin size = 0.02. 
 
Infusion analysis with LTQ-Orbitrap.  
Stem extracts were prepared as described in the procedure for LC-MS analysis. Stem 
extract (3 µL) was transferred to a nano-electrospray tip (1 µm, Humanix) from the 
bottom. The tip was then set on the nano-electrospray ionization (nano-ESI) ion source 
attachment. Mass spectrometric detection was performed on LTQ Orbitrap Velos Pro. 
The spray voltage for positive measurement was 1,000 V. Alkaloid detection was 
performed in the range of m/z 100-1,000 and m/z 385-550. The spectrometer was 
calibrated by polytyrosine (CS Bio) before experiments. MS/MS analyses of alkaloids 
with known standards were also conducted. Data analysis was conducted using Xcalibur 
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software (Thermo Fisher Scientific). Target mass peaks were detected in ± 5 ppm range, 
relative to the theoretical mass of TIA.  
 
Single-cell MS in C. roseus stem tissue.  
To identify cell-specific alkaloid localizations, I used live single-cell video mass 
spectrometry, termed “Single-cell MS” analysis (Mizuno et al., 2008). Longitudinal 
sections (100 µm thickness) of the stem were prepared with a microtome (Plant 
Microtome MTH-1; NKsystem), washed with ultrapure water to remove alkaloid 
contamination, and specimens were then mounted on a glass slide fixed with 
double-faced adhesive tape and monitored with a stereomicroscope (M205FA; Leica 
Microsystems). The contents of single cells from four different cell types, namely 
idioblast cells, laticifer cells, parenchyma cells and epidermal cells, were sucked into a 
gold-coated glass capillary nano-electrospray tip via tubing using a syringe under the 
stereoscopic microscope (Fig. 4). After the addition of 3 µL of ionization solvent (0.5% 
formic acid in methanol) into the nanoelectrospray tip from the bottom, the tip was set 
on a nano-ESI ion source attachment. Mass spectrometric detection was performed on 
LTQ Orbitrap Velos Pro. The spray voltage for positive measurement was 1,000 V. 
Alkaloid and secologanin detection was mainly performed in the range of m/z 100-1,000. 
Strictosidine was detected in the range of m/z 385-550 in samples. The spectrometer 
was calibrated with polytyrosine before experiments. Data analysis was conducted by 
using Xcalibur software. Target mass peaks were detected within ± 5 ppm, compared 
with the theoretical mass. Because no isomers of serpentine (alstonine), 
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demethoxyvindoline and strictosidine were found in the extract of whole stem tissue by 
LC-MS analysis, I quantified these alkaloids in each of the four kinds of cell types by 
semiquantitative calculation using Single-cell MS data on m/z intensity values of 349.15, 
389.14, 427.22 and 531.23, which were normalized to values of the total ion intensities 
(y axis of Fig. 12 shows percent of intensity normalized by the value of the total ion 
intensities). 
 
PCA analysis.  
Principal component analysis (PCA) of both technologies was conducted with 
MarkerView software (version1.2.1; AB Sciex) on 12 samples (three samples per cell 
type) for grouping each cell type (idioblast cell, laticifer cell, parenchyma cell and 
epidermal cell). I used total peaks, which were selected under the condition 
signal-to-noise ratio ≧ 3. 
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Figure and Table 
 
Fig. 2. TIA metabolic pathway in Catharanthus roseus. Purple font represents TIA 
enzymes localized in epidermal cells. Green represents the TIA enzyme localized in 
parenchyma cells. Blue represents TIA enzymes localized in idioblast cells and laticifer 
cells.  
 33 
Abbreviation, LAMT : Loganic acid O-methyltransferase, SLS : Secologanin synthase, 
TDC : Tryptophan decarboxylase, STR : Strictosidine synthase, SGD : Strictosidine 
β-glucosidase, T16H : Tabersonine 16-hydroxylase, 16OMT : 16-Hydroxytabersonine 
O-methyltransferase, NMT : 16-Methoxy-2,3-dihydro-3-hydroxy-tabersonine 
N-methyltransferase, D4H : Desacetoxyvindoline 4-hydroxylase, DAT : 
Deacetylvindoline 4-O-acetyltransferase. 
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Fig. 3. MS images of C. roseus stem longitudinal section. Most TIA localized in 
idioblast cell and laticifer cell. (A) m/z 415.1001 (Loganic acid). (B) m/z 429.1157 
(Loganin). (C) m/z 427.1001 (Secologanin). (D) m/z 351.1703 (Cathenamine). (E) m/z 
353.1859 (Ajmalicine). (F) m/z 349.1546 (Serpentine). (G) m/z 355.2016 
(Stemmadenine). (H) m/z 367.2016 (16-Methoxytabersonine). (I) m/z 337.1910 
(Catharanthine). (J) m/z 427.2227 (Demethoxyvindoline). (K) MS image control. (L) 
Longitudinal section excited by UV. Color bar represents MS signal intensity. Scale bar 
= 1 mm. 
Abbreviation, IC : Idioblast cell, LC : Laticifer cell, PC : Parenchyma cell, EC : 
Epidermal cell, VB : Vascular bundle.  
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Fig. 4. Sampling of the four types of cells contents with nano-electrospray tip. (A) 
Idioblast cell emitting blue fluorescence under UV excitation, before sampling. (B) The 
same cell after contents were sucked up with nano-electrospray tip. (C) Idioblast cell. 
(D) Laticifer cell. (E) Parenchyma cell. (F) Epidermal cell. 
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Fig. 5. MS/MS analysis of m/z 337.19. (A) Catharanthine standard (LC-MS). (B) 
Catharanthine standard (Infusion). (C) Tabersonine standard (LC-MS). (D) Tabersonine 
standard (Infusion). (E) Idioblast cell sample (Single-cell MS). (F) Laticifer cell sample 
(Single-cell MS). (G) Parenchyma cell (Single-cell MS). (H) Epidermal cell (Single-cell 
MS). (I) Stem sample m/z 337.19 specific MS/MS fragment (Infusion).  
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Fig. 6. MS/MS analysis of m/z 349.15. (A) Serpentine standard (LC-MS). (B) 
Serpentine standard (Infusion). (C) Idioblast cell sample (Single-cell MS). (D) Laticifer 
cell sample (Single-cell MS). (E) Stem sample m/z 349.15 specific MS/MS fragment 
(Infusion). 
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Fig. 7. MS/MS analysis of m/z 353.18. (A) Ajmalicine standard (LC-MS). (B) 
Ajmalicine standard (Infusion). (C) Idioblast cell sample (Single-cell MS). (D) Laticifer 
cell sample (Single-cell MS). (E) Stem sample m/z 353.18 specific MS/MS fragment 
(Infusion).  
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Fig. 8. MS/MS analysis of m/z 427.22. (A) Idioblast cell sample (Single-cell MS). (B) 
Laticifer cell sample (Single-cell MS). (C) Stem sample m/z 427.22 specific MS/MS 
fragment (Infusion).  
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Fig. 9. MS/MS analysis of m/z 531.23. (A) Stem sample m/z 531.23 specific MS/MS 
fragment (LC-MS). (B) Idioblast cell sample (Single-cell MS). (C) Laticifer cell sample 
(Single-cell MS). (D) Stem sample m/z 531.23 specific MS/MS fragment (Infusion). 
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Fig. 10. PCA of metabolome data according to cell type. (A) PCA derived from 
intensities of idioblast cell, laticifer cell, parenchyma cell and epidermal cell samples in 
Imaging MS analysis. (B) PC loadings derived from all m/z peaks of idioblast cell, 
laticifer cell, parenchyma cell and epidermal cell samples in Imaging MS analysis. (C) 
PCA derived from intensities of idioblast cell, laticifer cell, parenchyma cell and 
epidermal cell samples in Single-cell MS analysis. (D) PC loadings derived from all m/z 
peaks of idioblast cell, laticifer cell, parenchyma cell and epidermal cell samples in 
Single-cell MS analysis. (B and D) Blue points show monoisotopic and isotope data, 
and pale blue points show undefined data. Many TIA compounds were detected from 
idioblast cell and laticifer cell spectra. Red underbar shows TIA related ion peak. Green 
underbar shows iridoid related ion peak. 
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Fig. 11. LC chromatogram of catharanthine specific MS/MS fragment. (A) LC 
chromatogram of catharanthine standard (LC-MS). (B) Extracted chromatogram of 
catharanthine standard specific MS/MS fragment ion (m/z 93.07). (C) Extracted 
chromatogram of catharanthine standard specific MS/MS fragment ion (m/z 133.07). 
(D) Extracted chromatogram of stem sample (m/z 337.19). (E) Extracted chromatogram 
of stem sample of catharanthine specific MS/MS fragment ion (m/z 93.07). (F) 
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Extracted chromatogram of stem sample of catharanthine specific MS/MS fragment ion 
(m/z 133.07).  
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Fig. 12. Semiquantitative analysis of TIAs calculated by Single-cell MS analysis data. 
(A) Serpentine was detected in idioblast cell and laticifer cell (m/z 349.15). (B) 
Secologanin was detected in epidermal cell (m/z 389.14). (C) Demethoxyvindoline was 
detected in all cell types (m/z 427.22). (D) Strictosidine was detected in idioblast cell 
and laticifer cell (m/z 531.23). The y axis shows percent of intensity normalized by the 
value of the total ion intensity of each sample. Values are the mean of three 
measurements (± SEM). 
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Fig. 13. Cell-specific localization of TIA in C. roseus stem tissue. Most TIA localized 
in the idioblast cells and laticifer cells.  
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Chapter 2 : 
Cell-specific TIA localization in Catharanthus roseus leaf tissue 
 
Summary 
Catharanthus roseus (L.) G. Don is a medicinal plant well known for producing 
bioactive compounds such as vinblastine and vincristine, which are classified as 
terpenoid indole alkaloids (TIAs). Although the gene expressions of TIA producing 
enzymes have been studied well in C. roseus suspension-cultured cell and leaf tissue, 
the localization of TIA intermediates at the cellular level in the leaf tissue has not been 
revealed directly. In this chapter, I have succeeded in showing cell-specific TIA 
localization in C. roseus leaf tissue in addition to the stem tissue shown in Chapter 1, 
with Imaging MS and Single-cell MS. These metabolomic studies revealed that most 
iridoid compounds localized in epidermal cells, but major TIAs including serpentine 
and vindoline localized in idioblast cell and laticifer cell. Interestingly, strictosidine and 
catharanthine are also accumulated in C. roseus among epidermal cell, idioblast cell and 
laticifer cell. Moreover, I measured metabolome data in laticifer cells of leaf 
primordium. Comparing the present metabolome data to our former analysis of the stem 
tissue, I found that TIA biosynthesis in idioblast cell might be differentiated dependent 
on the different tissues or growth stages of the same tissue.  
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Introduction 
Catharanthus roseus (L.) G. Don (Apocynaceae) is one of the best-characterized 
Terpenoid indole alkaloids (TIA) producing plants (Van Der Heijden et al., 2004; 
Gigant et al., 2005; Kavallaris, 2010). Leaf extracts of C. roseus have still been the sole 
source of vindoline and catharanthine, both of which are monomeric precursors for the 
commercial production of vinblastine (O’Keefe et al., 1997).  
 The current understanding of TIA metabolism in C. roseus, which has been 
mainly deduced from studies on leaf tissues, was shown in the previous section, that is, 
iridoid metabolism begins in IPAP cells and that loganic acid produced in IPAP cells is 
transferred to epidermal cells. Further synthesis involving secologanin and strictosidine 
also occurs in the epidermal cells. Finally, a TIA intermediate, desacetoxyvindoline 
moves to the idioblast cell or/and laticifer cell and TIAs are accumulated in the vacuole 
of those cells (Fig. 14) (Yoder et al., 1976; Burlat et al., 2004; Dugé de Bernonville et 
al., 2015).  
In Chapter 1, I have shown the cell-specific localization of intermediates of 
TIA metabolism in the stem tissue in C. roseus, using Imaging MS and Single-cell MS 
(Yamamoto et al., 2016). In this measurement, loganin and secologanin are localized in 
the epidermal cells similar to localization of iridoid biosynthetic enzymes (LAMT : 
Loganate O-methyltransferase, SLS : Secologanin synthase). Most of TIAs including 
strictosidine and serpentine, however, localized in both idioblast cells and laticifer cells 
of C. roseus stem tissue (Yamamoto et al., 2016). The new aspect of localization of 
TIAs in C. roseus stem tissue made us suppose that the TIA pathway localization in the 
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stem tissue might be different in the leaf tissue. Thus far, the actual localization of TIA 
intermediates at the cellular level has not been directly measured in C. roseus leaf 
tissues. 
 In this chapter, I have applied cutting-edge methods of Imaging MS and 
Single-cell MS for detecting metabolites in situ at the cellular level in leaf tissue of C. 
roseus as well as the stem tissue conducted in Yamamoto et al. (2016). Since leaf cell 
size is much smaller than that of stem tissue, spatial resolution caused technical 
difficulties to detect metabolites at the cellular level. By improving methods of laser 
irradiation for Imaging MS and of micro-capillary and video-assisted system for 
Single-cell MS, I elucidated cell-specific TIA localization in leaf tissue of C. roseus.  
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Result 
Localization of idioblast cells and laticifer cells in C. roseus leaf tissue.  
C. roseus leaf tissue is composed of various types of cells : Leaf primordium laticifer 
cell (LPLC), Internal phloem associated parenchyma cell (IPAP), Leaf epidermal cell 
(LEC), Palisade tissue parenchyma cell (PTPC), Spongy tissue parenchyma cell (STPC), 
Palisade tissue idioblast cell (PTIC), Spongy tissue idioblast cell (STIC), Leaf laticifer 
cell (LLC) (Fig. 15). In the cross sections, idioblast cells were randomly found in 
parenchyma tissues and elongated laticifer cells were localized near the vascular 
bundles (xylem) (Fig. 15). Idioblast cells and laticifer cells were easily distinguishable 
from parenchyma cells by blue autofluorescence emitted from the chemical compounds 
accumulated in these cells when the specimen was excited by UV (Mersey et al., 1986; 
Carqueijeiro et al., 2016). The autofluorescence of laticifer cells derived from 
serpentine was observed in leaf primordium (Fig. 15). Morphogenesis of both idioblast 
cells and laticifer cells started at the leaf primordium and the number of idioblast cells 
and laticifer cells increased as leaf expands (Fig. 15). 
 
Imaging MS analysis in C. roseus leaf cross-section.  
When I investigated the localization of TIAs in C. roseus stem tissue with the Imaging 
MS, I measured it with 20 µm spatial resolution, because the size of cells in the stem 
tissue is much larger than that of cells in the leaf tissue. Diameter of leaf cells, such as 
epidermal cell, is about 10 µm. When I measured leaf tissues with 20 µm spatial 
resolution, I could identify where those compounds localized in leaf sections, but it is 
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difficult to distinguish which kinds of cells TIAs localized (Fig. 16). In order to study 
the localization of TIA in the leaf tissue precisely, I need to improve spatial resolution 
(10 µm) of Imaging MS analysis by adjusting laser diameter and strength, compared to 
the data obtained when I measured longitudinal section of C. roseus stem tissue. By the 
improvement of laser radiation system by Dr. Takahashi’s excellent technique, I 
succeeded in detecting various TIA compounds in leaf tissue precisely, although total 
ions created by MALDI ionization decreased (Figs. 16 and 17). 
In this experiment, I have detected that loganic acid clearly localized near the 
vascular bundle and epidermal cells (Fig. 17A). Previous report suggested that 
catharanthine, strictosidine, loganin and secologanin localized in the epidermal cells. 
However, my results showed that most TIAs including catharanthine and strictosidine 
also localized in the idioblast cells (Fig. 16). Although it has been proposed that most 
TIAs were synthesized in the epidermal cells based on the in situ hybridization 
experiments (Fig. 14) (St-Pierre et al., 1999), MS images revealed that various TIAs, 
including vindoline, ajmalicine and serpentine, were accumulated not in the epidermal 
cell but in the idioblast cell and laticifer cell (Figs. 16 and 17).  
 
Single-cell MS analysis in C. roseus leaf tissue.  
In order to obtain quantitative data and MS/MS spectrum data of various TIAs that 
complement the results of Imaging MS, I conducted Single-cell MS analyses on internal 
phloem associated parenchyma cell (IPAP), Leaf epidermal cell (LEC), Palisade tissue 
parenchyma cell (PTPC), Spongy tissue parenchyma cell (STPC), Palisade tissue 
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idioblast cell (PTIC), Spongy tissue idioblast cell (STIC), and Leaf laticifer cell (LLC) 
(Fig. 15). When I measured cell contents in C. roseus stem tissue, I detected unstable 
ionization time which means the detection time decreased the intensities of peaks 
because of nano-electrospray method. This nano-electrospray analysis is unstable 
compared to the conventional electrospray analysis. In this study, I attempted to add 
external standard in elution buffer (0.5% formic acid in methanol solved 1 ppm 
vindoline-d3) so as to correct the observational error dependent on the nano-spray 
analysis. 
I conducted target mass analysis of C. roseus TIA using Single-cell MS and 
LC-MS data (Tables 6 and 7). The mass spectra of idioblast cells and laticifer cells 
showed that major TIA peaks including catharanthine (m/z 337.19), serpentine (m/z 
349.15) and vindoline (m/z 457.23) were detected as primal peaks in those spectra. 
Catharanthine (m/z 337.19) was also detected in the mass spectra of parenchyma cells 
and epidermal cells. 
I examined MS/MS analyses of a peak having m/z 337.19 in order to clarify 
whether this is catharanthine, tabersonine or other alkaloids (Table 8). As a result of 
MS/MS, a catharanthine-specific fragment peak (m/z 93.07) from all types of cells 
showing m/z 337.19 was detected (Tables 6 and 8) (Yamamoto et al., 2016). The result 
of LC-MS/MS in C. roseus leaves also supported that m/z 337.19 in C. roseus leaf 
tissue is entirely composed of catharanthine. These analyses strongly suggested that 
catharanthine also accumulated in the idioblast cells and laticifer cells. MS/MS 
fragments corresponding to serpentine (m/z 349.15) and vindoline (m/z 457.23) were 
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detected in Single-cell MS and LC-MS/MS analyses (Tables 6 and 8 and Fig. 18) 
(Yamamoto et al., 2016). Moreover, I speculated on the possible TIA identities of 
several other peaks (Table 7). In order to determine whether these peaks were real TIAs, 
their MS/MS fragments in a similar manner as a former experiment of the stem tissue 
was analyzed (Table 8).  
 
Semi-quantitative analysis of Single-cell MS.  
The metabolome of C. roseus leaf tissues was analyzed using LC-MS. I detected that a 
single peak at m/z 349.15, 389.14, 399.22, 415.22, 427.22, 457.23 and 531.23 
correspond to serpentine, secologanin, desacetoxyvindoline, deacetylvindoline, 
demethoxyvindoline, vindoline and strictosidine respectively (Table 7). Due to the 
LC-MS result, I can prospect that these m/z values show a single molecular species in 
each cell type of C. roseus leaf tissue (Yamamoto et al., 2016). Semi-quantitative 
calculations were made in regard to m/z 337.19, 349.15, 389.14, 399.22, 415.22, 427.22, 
457.23 and 531.23 ion peaks from the Single-cell MS data measured with mass range 
m/z = 100-1000 (Table 6). Most of TIAs (m/z 337.19, 349.15, 399.22, 415.22, 427.22, 
457.23 and 531.23) are accumulated in idioblast cells and laticifer cells. Secologanin 
and strictosidine, which are supposed to be produced in the epidermal cells, were 
detected in those epidermal cells, too. 
 
  
 60 
Comparison of semi-quantitative data of laticifer cells between leaf primordium 
and leaf tissue.  
The contents of specialized metabolites are different among the tissues. In previous 
research, I compared TIA contents in the first pair leaf and the stem tissue with 
LC-MS/MS. There was a large difference of vindoline contents between the first leaf 
and the stem samples. The first leaf sample accumulated more vindoline and vindoline 
intermediates than the stem tissue. In order to confirm whether vindoline biosynthetic 
pathway is activated in the first leaf, I measured contents of laticifer cells with 
Single-cell MS, which are suspected to accumulate vindoline and deacetylvindoline, in 
the leaf primordium (Fig. 19). The metabolome data of laticifer cells in the leaf 
primordium showed low accumulation of vindoline.  
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Discussion 
TIA production in the C. roseus leaf tissue.  
LC-MS analysis data of C. roseus leaf extracts showed that the major peaks from TIAs 
were catharanthine, vindoline and various vindoline intermediates (Table 7) (Yamamoto 
et al., 2016). To verify that these peaks were real TIAs, I measured chemical structures 
of commercially available TIAs by MS/MS analysis using the same MS apparatus 
(Table 8). As for TIAs peaks having no standards, such as vindoline intermediates, I 
tried to obtain MS/MS fragments and detected a skeleton specific MS/MS fragment 
(m/z 188) among the aspidosperma skeleton. Interestingly, m/z peaks of vindoline 
intermediates, such as desacetoxyvindoline and deacetylvindoline, were detected as a 
single peak with LC-MS analysis. There was no isomer (Table 7). Based on such 
MS/MS information, I deduced these TIA peaks as vindoline intermediates. 
I was able to confirm that idioblast cells and laticifer cells contained 
catharanthine, serpentine and ajmalicine, using standard MS/MS fragments data. To our 
surprise, not only stem tissue but also leaf tissue contained catharanthine in idioblast 
cells and laticifer cells. So far, it has been considered that catharanthine was transported 
to wax layer after biosynthesis in the epidermal cells in other C. roseus cultivars (cv. 
Little delicata) (Roepke et al., 2010; Yu et al., 2013). There might be the possibility that 
catharanthine is transported into idioblast cells and laticifer cells. The conversion from 
ajmalicine to serpentine may occur in the vacuoles of idioblast cells and laticifer cells, 
since these compounds also localized in idioblast cells and laticifer cells.  
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Improvement of Imaging MS.  
I needed to improve spatial resolution from previous condition, because the epidermal 
cells in leaf tissue are much smaller than every cell in the stem tissue. When the 
diameter of laser for ionization was changed, the ion intensity induced by laser radiation 
decreased. However, I finally succeeded in detecting alkaloids every 10 µm spatial 
resolution. These MS images were possible to distinguish each cell where TIAs 
localized. For example, MS images of m/z 457.23 showed that this compound localized 
in palisade tissue idioblast cell and spongy tissue idioblast cell (Fig. 17). 
 
Changes in vindoline accumulation in laticifer cells depending on leaf stages.  
The contents of vindoline were different between the stem and leaf tissues (Yamamoto 
et al., 2016). In order to investigate whether vindoline is produced in C. roseus idioblast 
cells and laticifer cells in the leaf tissue, I also measured laticifer cells localized in leaf 
primordium with Single-cell MS (Fig. 19). TIA composition in laticifer cells in leaf 
primordium was different from that of laticifer cells localized in the first pair leaves 
(about 1 cm). Interestingly, I could not detect in any vindoline intermediates, such as 
desacetoxyvindoline and deacetylvindoline in the leaf primordium. Vindoline 
biosynthetic pathway might be function in expanding leaf. Tabersonine 16-hydroxylase 
2 (T16H2), which is considered as a key enzyme to vindoline biosynthesis in leaf tissue 
(Fig. 14), seems to increase its activity as the leaf grows (from leaf primordium up to 
larger than 1 cm leaf) (Fig. 20).  
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Cell-specific localization of TIAs in C. roseus leaf tissue.  
It has been proposed that TIA biosynthesis initially occurs in IPAP cells and then the 
products move from IPAP cells to epidermal cells, parenchyma cells, idioblast cells and 
laticifer cells. It has been proposed that loganic acid is transferred from IPAP cells to 
epidermal cells and desacetoxyvindoline from epidermal cells to other cells (Fig. 1). 
This hypothesis is mainly based on in situ hybridization data and localization of 
mRNAs of genes encoding enzymes involved in TIA synthesis (Dugé de Bernonville et 
al., 2015). The actual localization of TIA molecules at the cellular level has been never 
detected (Mersey et al., 1986). 
Imaging MS data showed that loganin and secologanin localized in the 
epidermal cells (Fig. 17). Single-cell MS showed the same localization, as for 
secologanin (Fig. 18). Unfortunately, loganin was not detected by using Single-cell MS, 
because the ionization efficiency of this compound decreases by using electrospray 
ionization (ESI). These iridoid metabolites have previously been shown to be 
synthesized in the epidermal cells of C. roseus stem tissue (Dugé de Bernonville et al., 
2015), and this also was confirmed by using my analysis (Yamamoto et al., 2016). 
 I was not able to detect loganic acid and loganin ionized as a proton adducted 
ion in Single-cell MS analysis. Although I could not semi-quantify these substances, I 
assumed that loganic acid was localized in IPAP cells, according to MS image of m/z 
415.1001 (loganic acid) (Fig. 17A). 
Imaging MS and Single-cell MS data also showed that most TIAs, including 
catharanthine (m/z 337.19), were localized in the idioblast cells and laticifer cells (Table 
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6 and Figs. 16 and 18). These data contrast with previously published reports that 
showed catharanthine localized in the wax layer of the leaf tissue (Roepkea et al., 2010; 
Yu et al., 2013). The reasons for these differences are unclear but might reflect 
differences of cultivars. 
My measurements also showed that most alkaloids are localized in the 
idioblast cell and laticifer cell (Table 6). These data are consistent with a previous report 
which showed that serpentine, ajmalicine and vindoline accumulated in the fraction of 
idioblast cells (Mersey et al., 1986; Carqueijeiro et al., 2016; Yamamoto et al., 2016). 
These metabolome results showed that compound of m/z 531.23 (strictosidine) localized 
not only in the epidermal cells but also in the idioblast cells and laticifer cells (Table 6). 
Strictosidine might be transported from vacuole in epidermal cells as soon as it is 
produced, and accumulated in cells which have strictosidine transporter. It is also 
possible that symplasmic transport via plasmodesmata might drive movements of TIA 
intermediates between adjacent cells (Fig. 20). Further studies are needed to clarify how 
these compounds distribute between the different cell types. 
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Material and method 
Plant material and sample preparation.  
Observation of idioblast cells and laticifer cells with microscope.  
Extraction of TIAs from C. roseus tissues.   
LC-MS Analysis.  
 Those methods are described in Chapter 1. 
 
Chemicals.  
Commercially available TIA standards, catharanthine (Enzo Life Sciences), tabersonine 
HCl (AvaChem Scientific), ajmalicine (AdipoGen), serpentine hydrogen tartrate 
(ChromaDex), deacetylvindoline (Tronto Research Chemicals), vindoline (ChromaDex) 
and vindoline-d3 (Tronto Research Chemicals) were used. Strictosidine was divided 
from Dr. Sarah O’Connor (John innes centre). One ppm solutions of these chemicals 
were used as standards in LC-MS/MS analysis with LTQ Orbitrap (LTQ Orbitrap Velos 
Pro, Thermo Fisher Scientific, USA) used for the Single-cell MS (MS/MS) analysis. 
 
Imaging mass spectrometry.  
Cross sections (80 µm thickness) of C. roseus first leaf were prepared with a microtome 
(Plant Microtome MTH-1, NKsystem, Japan) and visually inspected with a fluorescent 
stereoscopic microscope (M250FA, Leica Microsystems, Germany). Suitable sections 
were then washed with MilliQ water to remove alkaloid contamination from dead cells 
and mounted on Indium Tin Oxide (ITO) glass slides (Luminescence Technology Co., 
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Hsin-Chu, Taiwan) using Cryoglue type I (SECTION-LAB Co. Ltd., Japan). The 
samples on glass slides were lyophilized by freeze-drying (Model 77400, LABCONCO 
Co. MO, USA) then sublimated by α-cyano-4-hydroxycinnamic acid (CHCA) with a 
conductive glass using a sublimation apparatus (ChemGlass CG-3038, ChemGlass Life 
Sciences). Mass spectrometric detection was performed on FT-ICR MS (APEX-Qe 
9.4T with dual source, Bruker Daltonics Inc., USA). The spatial resolution of Imaging 
MS was 10-20 µm. MS images were reconstituted using Lab-MSI (Takahashi et al., 
2015). Target mass peaks were detected in a bin size = 0.02. 
 
Single-cell MS in C. roseus leaf tissue.  
To identify cell-specific alkaloid localizations, I used live single cell video mass 
spectrometry, termed “Single-cell MS” analysis. Cross sections (100 µm thickness) of 
the leaf were prepared with a microtome (Plant Microtome MTH-1, NKsystem, Japan), 
washed with ultrapure water to remove alkaloid contamination, and then specimens 
were mounted on a glass slide fixed with double-faced adhesive tape and monitored 
with a stereomicroscope (M205FA, Leica Microsystems, Germany). The contents of 
single cells from eight different kinds of cell types, namely Leaf primordium laticifer 
cell (LPLC), Internal phloem associated parenchyma cell (IPAP), Leaf epidermal cell 
(LEC), Palisade tissue parenchyma cell (PTPC), Spongy tissue parenchyma cell (STPC), 
Palisade tissue idioblast cell (PTIC), Spongy tissue idioblast cell (STIC), Leaf laticifer 
cell (LLC), were sucked into a gold-coated glass capillary nano-electrospray tip via 
tubing using a syringe under the stereoscopic microscope (Fig. 15). After the addition of 
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3 µL of ionization solvent (0.5% formic acid and 1 ppm vindoline-d3 in methanol) into 
the nano-electrospray tip from the bottom, the tip was set on a nano-ESI ion source 
attachment. Mass spectrometric detection was performed on LTQ Orbitrap Velos Pro. 
The spray voltage for positive measurement was 1,000 V. Alkaloid detection was 
mainly performed in the range of m/z 100-1,000. The spectrometer was calibrated with 
poly-tyrosine before experiments. Data analysis was conducted by using Xcalibur 
software. Target mass peaks were detected within ± 5 ppm, compared to the theoretical 
mass. Since no isomers of m/z 337.19, 349.15, 389.14, 399.22, 415.22, 427.22, 457.23 
and 531.23 ion peaks were found in the extract of whole leaf tissue by LC-MS analysis 
(Yamamoto et al., 2016), I quantified these alkaloids in each of the seven kinds of cell 
type by semi-quantitative calculation using Single-cell MS data on m/z intensity values 
of above ion peaks. When I compare the contents of TIA in laticifer cells between leaf 
primordium and leaf, the peak intensities of TIAs were corrected with values of the 
vindoline-d3 ion intensities. 
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Figure and Table 
 
Fig. 14. Speculated TIA metabolic pathway in Catharanthus roseus. Purple font 
represents TIA enzymes localized in epidermal cells. Blue represents TIA enzymes 
localized in idioblast cells and laticifer cells. Abbreviation, LAMT : Loganic acid 
O-methyltransferase, SLS : Secologanin synthase, TDC : Tryptophan decarboxylase, 
STR : Strictosidine synthase, SGD : Strictosidine β-glucosidase, T16H : Tabersonine 
 69 
16-hydroxylase, 16OMT : 16-Hydroxytabersonine O-methyltransferase, T3O : 
tabersonine 3-oxygenase, T3R : Tabersonine 3-reductase, NMT : 
16-methoxy-2,3-dihydro-3-hydroxy-tabersonine N-methyltransferase, D4H : 
Desacetoxyvindoline 4-hydroxylase, DAT : Deacetylvindoline 4-O-acetyltransferase.  
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Fig. 15. Localization of idioblast cells and laticifer cells in C. roseus leaf tissue. (A) 
Leaf expansion from leaf primordium. (B) The cross section of C. roseus leaf (about 1 
cm). Scale bar = 100 µm. 
Abbreviation, LPLC : Leaf primordium laticifer cell, IPAP : Internal phloem associated 
parenchyma cell, LEC : Leaf epidermal cell, PTPC : Palisade tissue parenchyma cell, 
STPC : Spongy tissue parenchyma cell, PTIC : Palisade tissue idioblast cell, STIC : 
Spongy tissue idioblast cell, LLC : Leaf laticifer cell.  
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Fig. 16. MS images of C. roseus leaf section measured with 20 µm spatial resolution.  
(A) m/z 415.1001 (Loganic acid). (B) m/z 429.1157 (Loganin). (C) m/z 427.1001 
(Secologanin). (D) m/z 531.2333 (Strictosidine). (E) m/z 351.1703 (Cathenamine). (F) 
m/z 353.1859 (Ajmalicine). (G) m/z 349.1546 (Serpentine). (H) m/z 337.1910 
(Catharanthine). (I) m/z 427.2227 (Vindorosine (Demethoxyvindoline)). (J) m/z 
457.2333 (Vindoline). Color bar represents MS signal intensity.  
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Fig. 17. MS images of C. roseus leaf section measured with 10 µm spatial resolution. 
Most TIA localized in idioblast cell and laticifer cell. (A) m/z 415.1001 (Loganic acid). 
(B) m/z 429.1157 (Loganin). (C) m/z 427.1001 (Secologanin). (D) 457.2333 (Vindoline). 
Color bar represents MS signal intensity.  
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Fig. 18. Semi-quantitative analysis of TIAs calculated by using Single-cell MS analysis 
data. (A) Catharanthine (m/z 337.19). (B) Serpentine (m/z 349.15). (C) Secologanin (m/z 
389.14). (D) Desacetoxyvindoline (m/z 399.22). (E) Deacetylvindoline (m/z 415.22). (F) 
Demethoxyvindoline (m/z 427.22). (G) Vindoline (m/z 457.23). (H) Strictosidine (m/z 
531.23). Y-axis shows percent of intensity normalized by the value of the total ion 
intensity of each sample. Values are the mean of three measurements (± SEM).  
Abbreviation, IPAP : Internal phloem associated parenchyma cell, LEC : Leaf 
epidermal cell, PTPC : Palisade tissue parenchyma cell, STPC : Spongy tissue 
parenchyma cell, PTIC : Palisade tissue idioblast cell, STIC : Spongy tissue idioblast 
cell, LLC : Leaf laticifer cell.  
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Fig. 19. TIA contents in leaf laticifer cell (LLC) and leaf primordium laticifer cell 
(LPLC). (A) Intensity of serpentine content. (B) Intensity of demethoxyvindoline 
content. (C) Intensity of vindoline content. Values are the mean of three measurements 
(± SEM). 
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Fig. 20. Cell-specific localization of TIA in C. roseus leaf tissue. Vindoline is 
accumulated in idioblast and laticifer cells of elongated leaf.  
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Chapter 3 : 
Molecular analyses of idioblast cells and laticifer cells in Catharanthus roseus 
 
Summary 
The cell-specific localizations of TIA in C. roseus stem and leaf tissues have been 
studied in the former chapters and I revealed that most TIAs localized in idioblast cell 
and laticifer cell. These results are different from the past findings. The results of TIA 
localization also suggest that idioblast cell and laticifer cell play an important and a 
similar role in TIA metabolism in C. roseus plant. However, the molecular mechanisms 
of biosynthesis and accumulation of TIA intermediates in idioblast cell and laticifer cell 
have not been studied at all. In this chapter, I have conducted cell-specific RNA-seq 
analyses in order to discover the genes expressed in these cells. 
 At first, I observed the differentiation of idioblast cells and laticifer cells in 
stem and leaf tissues. I found that idioblast cells and laticifer cells are not differentiated 
in upper part of stem compared to other tissues. Moreover, I have conducted 
metabolome analysis to confirm what kinds of TIAs are contained among upper part of 
stem, lower part of stem and leaf. These metabolome data showed the differences of 
TIA accumulation between stem and leaf tissues. The content of serpentine, which 
shows autofluorescence excited by UV, increased in lower part of the stem. This result 
coincides that lower part of stem have many idioblast cells. Furthermore, I tried to 
obtain those idioblast cell-specific RNA-seq data by collecting idioblast cells from 
lower part of stem in order to investigate the differentiation in idioblast cell in the stem 
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tissue. The cell-specific RNA-seq analysis in stem tissues revealed that major latex like 
protein and the candidates of specialized metabolites transporters and enzymes are 
highly expressed in the fraction of idioblast cell. 
For further analysis of the idioblast cells, I have isolated idioblast cells from 
leaf tissues with Fluorescence activated cell sorting (FACS). By the measurement of 
gene expression in isolated idioblast cells, higher expressions of genes of TIA enzymes 
localized in idioblast cells were detected. These results help us to consider the role of 
idioblast cell and laticifer cell for specialized metabolism in C. roseus plants. 
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Introduction 
The secretory cells are classified as cells differentiated from ground parenchyma cells 
and contain a variety of substances secreted : balsams, resins, oils, tannins, mucilages, 
gums, crystals, etc. They have been classified as secretory idioblasts conspicuously 
differed from neighboring cells (Esau, 1965).  
One of famous secretory cells is the laticifer cell. Laticifer cells are consist of 
a single cell or a series of fused cells containing so-called fluid latex. These kinds of 
cells are localized in various tissues of the plant body. Latex containing plants are 
estimated to amount about 12,500 species (over 20 plant families) (Hagel et al., 2008). 
Although it has been considered that laticifer cells have various roles, such as regulator 
related to water balance or protection against herbivores, their conclusive roles in the 
plant life is still lacking (Esau, 1965; Pramoolkit et al., 2014). The most accepted 
interpretation of the role of the laticifer cells is that they form an excretory system, same 
as other secretory cells. Laticifer cells accumulate many substances that are commonly 
recognized as excretory, and such substances are more abundant than nutrition (Esau, 
1965). For example, latex contains specialized metabolites such as many kinds of 
terpenoids, cardiac glycosides, alkaloids, cannabinoids and tannins. Since most of those 
specialized metabolites are cytotoxic, it is also considered that laticifer must have a role 
as sequestering cells and defensive cells (Facchini et al., 2005; Hagel et al., 2008; Huber 
et al., 2016). In opium poppy, most alkaloids, such as morphine and codeine, are 
accumulated in the latex of articulated cells called laticifers (Facchini et al., 2008).  
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In Chapter 1 and 2, I introduced that Catharanthus roseus (L.) G. Don plants 
have produced those TIAs via various cells including IPAP cells, epidermal cells, etc. 
Finally, they are accumulated in idioblast cells and laticifer cells classified as 
nonarticulated, unbranched laticifers (Thamm et al., 2016; Yamamoto et al., 2016). 
However, Imaging MS analysis and Single-cell MS analysis revealed that the different 
localizations of TIAs. Especially, strictosidine were existing at the site which is 
different from producing site based on the localization of TIA enzymes (Yamamoto et 
al., 2016). Considering these results, I suppose that idioblast cells and laticifer cells are 
also related to not only an excretory system of toxic TIA compounds but also the TIA 
intermediates biosynthesis closely. I am also considering the possibility that the 
transporters of strictosidine and/or other TIAs intermediates might be functioning to 
localize them in those cells. 
 These days, RNA-seq data of C. roseus revealed TIA biosynthesis related 
genes, including transporters, transcription factors and enzymes. For instances, master 
regulators (BIS1, BIS2) that activates the biosynthesises of the iridoids were discovered 
by transcriptome analysis and fuctional screening (Van Moerkercke et al., 2015). 
Furthermore, triterpenoids enzymes and catharanthine transporter (CrTPT2 : a member 
of the pleiotropic drug resistance (PDR) family of ABC transporters) were discovered 
from the EST and RNA-seq database from epidermal cells (Murata et al., 2008; Yu et 
al., 2013).  
In this chapter, I used transcriptome analyses and tissue-specific metabolome 
analyses in order to find the candidates of TIA transporters and idioblast specifically 
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expressed genes. Further, in order to investigate mechanism of TIA synthesis in the 
idioblast cells in leaf tissue, I attempted to isolate idioblast cells by using FACS.  
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Result 
Localization of idioblast cells and laticifer cells in C. roseus aerial part.  
Idioblast cells and laticifer cells of C. roseus exist in every tissues and organs, such as 
stem, leaf, flower and root. In leaf tissue, laticifer cells also localized in leaf primordium. 
On the other hand, it was difficult to observe both idioblast cells and laticifer cells in the 
youngest internode and second internode of the stem tissue, when I observed under UV 
(Fig. 21).  
 
LC-MS analysis in C. roseus stem tissue.  
In order to investigate TIA content in the first leaf (Yamamoto et al., 2016), the upper 
part of stem and the lower part of stem, I measured them by using LC-MS. Serpentine 
was accumulated in the lower part of stem compared to the upper part of stem. The 
catharanthine, tabersonine, ajmalicine and vindoline contents of leaf tissues were higher 
than that of stem tissues (Yamamoto et al., 2016). According to the present study, I 
succeeded in detecting the differences of these TIAs contents between upper and lower 
part of stem tissues. The upper part of stem (about 0.643 µg mg-1 FW) accumulated 
more catharanthine than the lower part of stem (about 0.282 µg mg-1 FW). The content 
of tabersonine is similar amounts in both stem parts. The upper part of stem was 
accumulated less ajmalicine and serpentine than the lower part of stem (Fig. 22). 
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RT-PCR in tissue-specific fraction.  
Metabolome analyses revealed that the tissue-specific alkaloid accumulation. In order to 
investigate how such a difference occurs, I conducted RT-PCR of TIA 
biosynthesis-related genes in C. roseus stem and leaf tissues (Fig. 22). Tabersonine 
16-hydroxylase 2 (T16H2) produces 16-hydroxytabersonine which is the initial 
substance in a vindoline pathway. Since it is suggested that T16H2 coordinate vindoline 
and vindorosine pathways, I investigated the gene expression of this enzyme. The gene 
expression of T16H2 was upregulated in leaf tissue compared to the stem tissues. 
Furthermore, the gene expression of T16H2 is activated in the upper part of stem tissue 
compared to the lower part of stem (Fig. 22). 
 
RNA-seq analyses with cell-specific samples.  
In cell-specific RNA-seq analysis, I used a method, which is newly-developed by 
Hitachi research group for very small tissues (see Material and Methods and Kajiyama 
et al., 2015). By using a special equipment, I collected idioblast cell and parenchyma 
cell fractions from under third internode where these cells have already accumulated 
enough TIAs. On the other hand, because serpentine has not been produced well in the 
youngest and second internodes compared to other internodes, I could not discover an 
immature idioblast cell under UV excitation (Fig. 21). The results of cell-specific 
RNA-seq showed that some of the enzyme genes related to lipid and specialized 
metabolite synthesis were upregulated in the fraction of idioblast cells (Fig. 23 and 
Table 9).  
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Isolation of idioblast cells from C. roseus leaf tissue.  
In order to obtain the candidate genes expressed in the idioblast cells and to conduct cell 
biological experiments, I tried to isolate idioblast cells from leaf tissue. Idioblast cells 
have the features of higher intensity of blue autofluorescence (Figs. 24-26) excited by 
UV. I used this feature for separating idioblast protoplasts from parenchyma fraction by 
using FACS. I succeeded in obtaining the fraction of enriched idioblast cells. 
I also tried to investigate the gene expression of idioblast cell enrichment 
fraction. The result of gene expression analysis in the idioblast cell fraction showed that 
the genes related to vinblastine production are upregulated (Figs. 24-26). 
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Discussion 
Accumulation of serpentine and other TIAs in lower part of stem in C. roseus.  
Since serpentine was more accumulated in the lower part of stem compared to the upper 
part of stem (Fig. 22), it is suggested that serpentine biosynthesis is progressing as the 
stem grows. I also measured ajmalicine contents in each tissue. Interestingly, ajmalicine 
content of lower part of tissue was higher than that of upper part of stem tissue, too. It is 
the high possibility that serpentine is produced in lower part of stem. Since it has been 
considered that peroxidases (Enzyme commission numbers (EC) 1.11.1.7) are involved 
to serpentine conversion from ajmalicine (Blom et al., 1991), I need to investigate 
certain peroxidases related to stem growing or senescence in order to detect serpentine 
biosynthesis enzyme. 
 
Tabersonine 16-Hydroxylase 2 (T16H2) might regulate the biosynthesis of 
vindoline and vindorosine among stem and leaf tissues in C. roseus.  
Tissue-specific TIA accumulation among stem and leaf tissues in C. roseus was 
detected by using LC-MS and Single-cell MS analyses (Yamamoto et al., 2016 and Fig. 
22). These results show that vindoline, vindorosine and serpentine biosynthesis 
regulated dependent on the tissues. Vindoline and vindorosine pathways in C. roseus 
have been revealed these days (Qu et al., 2015). It is considered that Tabersonine 
16-Hydroxylase 2 (T16H2) is involving to the differentiation of TIA metabolism. In 
order to reveal whether the differences of vindoline contents are resulted from the 
expression of T16H2 or not, the gene expression analysis of T16H2 in each tissue was 
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conducted. As a result, RT-PCR analysis showed that the expression of this gene was 
upregulated in expanded leaf tissue and almost no expression in the stem tissues (Fig. 
22). These results clearly suggest that T16H2 control vindoline accumulation in leaf 
tissues.  
 RNA-seq data of other groups showed the same results (Van Moerkercke et 
al., 2013; Van Moerkercke et al., 2015). This is a reason why vindorosine accumulated 
in idioblast cells and laticifer cells in the stem, instead of vindoline. It has been still 
unknown which transcriptional regulation is involved to the gene expression of T16H2.  
 
Pathogenesis-related (PR) protein in C. roseus tissue.  
PR proteins were induced under pathological or stress situation. I detected many genes 
of fungal resistance and bet v I family protein, including major latex protein (MLP), in 
RNA-seq analysis of idioblast cell fraction (Fig. 23). It is reported that MLP 
accumulated in latex of opium poppy (Nessler et al., 1985). These results also suggested 
that MLP protein localized in the idioblast cell and this cell has similar features with 
laticifer cell. Moreover, I detected the enzymes related to specialized metabolites 
synthesis, such as spermine synthase, in these RNA-seq data (Fig. 23). It is possible that 
other specialized metabolisms also occur in idioblast cells in C. roseus.  
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What kinds of transporter are involved to TIAs transport. 
Little is known about TIA transport system in C. roseus, compared to metabolic 
pathway. These days, the ABCG transporter (i.e. catharanthine transporter) has been 
identified (Yu et al., 2013). Furthermore, it has been also reported TIA transport system 
among organelles. Early researchers proposed that ion-trap mechanism for alkaloid 
accumulation in the vacuoles (Deus-Neumann et al., 1986). However, recent researchers 
suggest that TIAs are transported to the vacuoles of mesophyll cells in C. roseus 
thorough the H+/TIA antiport mechanism (Carqueijeiro et al., 2013).  
Even though it is the possibility that the plasmodesmata is involved to TIA 
transport among cells, I am considering that many kinds of transporters, such as ABCG 
transporter and antiporter, are involved to TIAs transport. Since the method for isolating 
idioblast cells with FACS was established (Fig. 24), I would like to investigate TIA 
transporters localized in these cells in the near future. 
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Material and method 
Observation of idioblast cells and laticifer cells with microscope.  
Extraction of TIAs from C. roseus tissues.   
LC-MS Analysis.  
 Those methods are described in Chapter 1. 
 
Plant material and sampling for metabolome analysis.  
C. roseus (L.) G Don (cv. Equator White Eye) was grown at 25 °C under 14 light/10 
dark h white fluorescent light photoperiod in a growth chamber (NKsystem). Seeds 
were purchased from Sakata Seed Corporation. 
 Upper part of stem, lower part of stem and first pair leaf of C. roseus were 
harvested from about 3-month-old plants (Fig. 22).  
 
Counting the number of idioblast cells and laticifer cells.  
The central longitudinal section in C. roseus stem tissue was used for counting the 
number of cells. After I took photos of longitudinal sections under microscope, those 
photos were integrated on single picture by using e-Tiling (Mitani corporation). The 
number of idioblast cells and laticifer cells were counted with Image-J. 
 
Sampling from the longitudinal section of C. roseus stem tissue.  
The longitudinal section of C. roseus stem tissue was mounted on a 4% agarose gel 
containing Tris-HCl pH 8.0 and 1 mM EDTA. The fraction of idioblast cells or 
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parenchyma cells were sampled by using the homemade sampling device under 
stereomicroscope. The fractions of these cells were placed into 0.5 µL of PLC buffer 
(RNeasy, Qiagen) in PCR tubes (Axygen), then these samples were frozen in liquid 
nitrogen in a moment.  
 
cDNA preparation for RNA-seq.  
I followed the protocol (Kajiyama et al., 2015). After these samples were ground with 
pestle, the ground fractions were collected with centrifuge. I added buffer solution (2.6 
µL PBS (pH 7.4), 0.36 µL 10×DNaseⅠBuffer and 0.5 µL DNaseⅠ(Life 
Technologies)) to the sample solution for degrading genomic DNA. This mixture 
solution was kept at room temperature for 5 min, then DNaseⅠ was inactivated by 
adding 1.2 µL of EDTA (2.5 mM, pH 8.0) at 70℃ for 5 min. I used UP1VN-oligo 
immobilized beads (Dynabeads® MyOne™ Streptavidin C1, diameter; 1 µm, Dynal) 
suspension (107 of UP1VN-oligo immobilized beads, 1 µL 10 mM dNTP mixture and 
16.6 µL T&T Buffer) for cDNA producing. The mixture was heated at 70℃ for 5 min, 
then cooled down to 4℃ so as to hybridized oligo probes on beads to mRNA. I added 
9.0 µL RT solution (6 µL 5×RT Buffer, 1 µL DTT, 1 µL RNase OUT and 1 µL Super 
Script Ⅲ (Life Technologies)) for reverse transcription reaction. This mixture was 
shaken with 750 rpm at 50℃ for 30 min in incubator, then kept at 70℃ for 10 min and 
it was cooled down to 4℃ . After the supernatant removed from this mixture, 
cDNA-immobilized beads washed 50 µL T&T buffer and I added finally 6 µL T&T 
buffer for the dispersion of these beads.  
 94 
I added 6.0 µL of tailing solution (0.6 µL 10×PCR Buffer II (Life Technologies), 0.36 
µL 25 mM MgCl2, 0.18 µL 100 mM dATP, 0.3 µL RNase H (Life Technologies), 0.3 
µL TdT (Life Technologies) and 4.26 µL water) to solution of including cDNA library 
beads. This mixture was shaken with 750 rpm at 37℃ for 15 min in incubator, then 
kept at 70℃ for 10 min and it was cooled down to 4℃. I added 50 µL T&T buffer to 
this mixture for washing. After I removed supernatant, I added finally 12 µL T&T 
buffer for the dispersion of these beads. 
 
PCR amplification of cDNA.  
Amprified PCR were produced with anchored oligo2 primer (UP2VN-oligo; 5’-ATA 
TCT CGA GGG CGC GCC GGA TCC T (24)VN-3’, Integrated DNA Technologies), 
which hybridize on the poly(A) sequence of the first cDNA strands. After I added the 
solution (0.114 µL 100 µM UP2VN-oligo, 2.2 µL 10×Ex Taq Buffer, 2.2 µL 2.5 mM 
dNTP Mix, 0.19 µL of Ex Taq Hot start version (Takara bio) and 5.296 µL water) to the 
sample, it was heated at 95℃ for 3 min, 44℃ for 5 min, 72℃ for 6 min and finally 
cooled down to 4℃.  
 Furthermore I added 19.0 µL of amplification solution (0.418 µL of 100 µM 
oligo3 primer (UP1-oligo; 5’- ATA TGG ATC CGG CGC GCC GTC GAC T(24) -3’, 
SIGMA-ALDRICH), 1.9 µL of 10×Ex Taq Buffer, 1.9 µL of 2.5 mM dNTP Mix, 0.19 
µL of Ex Taq Hot start version and 14.592 µL of water) to the mixture, I conducted 
PCR (95℃ for 30 sec, 18 thermal cycles of 95℃ for 30 sec, 67℃ for 1 min and 
72 ℃ for 6 min). 
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I prepared cDNA in this way. I used those cDNA for cell-specific RNA-seq 
analysis. 
 
RNA-seq analysis of idioblast cell.  
I analyzed cell-specific RNA-seq data measured with Illumina GAIIx. I used fragments 
per kilobase of transcript per million mapped reads (FPKM) normalized with RPS9 in 
order to obtain idioblast cell-specific gene expression data from RNA-seq data (Fig. 23 
and Table 9). Table 9 shows genes whose expression level in the idioblast cell is over 
10 times higher than that in the parenchyma cell. 
 
FACS analysis.  
I used C. roseus leaves (about 3 months-6 months) so as to isolate idioblast cells with 
FACS. C. roseus leaves were incubated for 2.5 hours by protoplast making solution 
(Cellulase Y-C (1%), Macerozyme R-10 (0.5%) solved with protoplast solution (600 
mM sorbitol, 10 mM MES, 1 mM CaCl2, pH 6.0 with Tris). After making protoplast, I 
conducted density gradient centrifugation to remove epidermal cell. Then, I collected 
parenchyma cell fraction. I used parenchyma cell fraction filtered with 50 µm 
(BD-falcon) to separate idioblast cells by using FACS. In FACS analysis, idioblast cells 
were sorted by using parameter of FSC, SSC, APC-cy7 and AmCyan with sheath 
pressure 10psi, nozzle 130 µm, and flow rate from 1.0 to 3.0 (Fig. 24). 
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RNA extraction and cDNA synthesis of tissue-specific samples and FACS samples.  
RNA was extracted from tissue samples or/and protoplast samples by using RNeasy 
Plant Mini Kit (QIAGEN, Germany). I also used RNase-Free water DNase set 
(QIAGEN, Germany) in order to remove DNA contamination. 
I followed the protocol of RNeasy Plant Mini Kit to make cDNA of each 
sample. Oligo dT primer and AMV Transcriptase were used for obtaining first strand 
cDNA. I used 50 ng RNA of FACS samples or 100 ng RNA of tissue samples to make 
first strand cDNA. 
 
RT-PCR for tissue and cell-specific samples.  
I conducted tissue and cell-specific RT-PCR analysis (Figs. 22 and 26). The sequences 
of primers were used in Tables 10 and 11. I conducted PCR (94℃ for 1 min, 45 
thermal cycles of 94℃ for 15 sec, 65℃ for 20 sec and 72 ℃ for 30 sec, 72℃ 3 min) 
with thermal cycler. 
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Figure and Table  
 
Fig. 21. Idioblast cell distribution in C. roseus stem tissue. The number of idioblast cells 
and laticifer cells increases in the lower part of stem. (A) The number of idioblast cells. 
(B) The number of laticifer cells. Values are the mean of four measurements (± SEM).  
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Fig. 22. Vindoline synthesis in C. roseus stem and leaf tissues. (A) Sampling from C. 
roseus plant (Bar = 5 mm). (B) RT-PCR of T16H2 in stem and leaf tissues. 60S denotes 
ribosomal protein. (C) TIA content in each tissue. Values are the mean of three 
measurements (± SEM). 
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Fig. 23. Cell-specific RNA-seq analysis in C. roseus stem tissue. (A) MLP31 
(Caros022694.1). (B) Pathogenesis-related protein 10 (Caros014578.1). (C) ABC 
transporter A family member 3 (Caros000259.1). (D) Spermine synthase 
(Caros004793.1). (E) Cytochrome P450 (Caros001784.1). (F) Plastid-lipid-associated 
protein (Caros020215.1). Values are the mean of two measurements.   
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Fig. 24. Isolation of idioblast cell from leaf tissue with FACS. (A) Figure shows all 
particles derived from cells, organelles and the fractions of cell wall, in measuring by 
flow cytometer. (B) The fraction of P1 (Before cell sorting). (C) I collected cells that 
show the high value of blue autofluorescence and have low chlorophyll 
autofluorescence. (D) The fraction of P3 (After cell sorting).  
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Abbreviation, FSC : Forward scatter, SSC : Side scatter, IC : Idioblast cell. 
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Fig. 25. FACS analysis. I obtained each fraction, such as P1, P2 and P3, derived from 
the measurement of Fig. 24. (A) FSC value shows the size of cell. (B) SSC value shows 
the complexity inside cell. (C) AmCyan value shows the blue autofluorescence. (D) 
Images of P1 and P3 fraction. Values are the mean of three measurements (± SEM). 
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Fig. 26. RT-PCR of FACS samples. (A) RT-PCR results of TIA synthesis enzymes in 
the fraction of idioblast cells (P3 fraction) and that of parenchyma cells (P1 fraction). 
(B) TIA biosynthetic pathway in C. roseus. Orange font represents TIA enzymes 
localized in epidermal cells. Blue represents TIA enzymes localized in idioblast cells 
and laticifer cells. 
  
Secologanin
Tryptamine
Strictosidine Tabersonine
16-HydroxytabersonineDesacetoxyvindolineDeacetylvindolineVindoline
Catharanthine 3’,4’-Anhydrovinblastine
TDC
SGDSTR
T16H
D4HDAT
PRX1
Tryptophan
Loganin
Strictosidine aglycone






















	
Idioblast*cell*frac/on
Parenchyma*cell*frac/on
A
B
 104 
  
Ta
bl
e 
9.
 R
N
A
-s
eq
 a
na
ly
si
s o
f i
di
ob
la
st
 c
el
l (
To
p 
20
0)
G
en
e 
ID
D
et
ec
tio
n 
(G
en
e 
ID
: O
R
C
A
E
 d
at
ab
as
e)
Pa
re
nc
hy
m
a 
ce
ll
(F
PK
M
 n
or
m
al
iz
ed
w
ith
 R
PS
9)
Id
io
bl
as
t c
el
l
(F
PK
M
 n
or
m
al
iz
ed
w
ith
 R
PS
9)
St
em
 ti
ss
ue
(F
PK
M
 n
or
m
al
iz
ed
w
ith
 R
PS
9)
c1
44
79
_g
1
C
ar
os
00
43
46
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
1.
92
43
12
26
4
25
.2
35
36
52
8
4.
41
32
78
17
c1
39
77
_g
1
C
ar
os
00
78
33
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_K
po
l_
10
58
p4
)
0.
30
66
94
11
1
6.
08
51
90
42
2
1.
06
00
73
57
8
c2
57
19
_g
1
C
ar
os
00
99
44
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
)
0.
30
57
78
55
4
5.
60
81
79
69
6
0.
62
98
41
17
9
c1
56
0_
g1
C
ar
os
00
78
33
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_K
po
l_
10
58
p4
)
0.
24
78
39
69
5.
04
82
94
06
8
0.
37
13
40
33
3
c1
62
4_
g1
C
ar
os
00
78
33
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_K
po
l_
10
58
p4
)
0.
28
49
14
84
8
4.
93
06
85
24
8
0.
81
55
95
00
5
c7
11
1_
g1
C
ar
os
02
45
55
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_O
sI
_3
21
84
)
0.
29
85
61
89
9
4.
62
58
83
78
2
0.
08
28
92
62
1
c1
44
63
_g
1
C
ar
os
00
62
41
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
4.
32
79
16
45
0.
36
21
69
11
5
c1
15
56
_g
1
C
ar
os
01
62
98
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
()
__
(S
A
U
R
_f
am
ily
_p
ro
te
in
)
0.
10
82
09
40
4
3.
69
76
78
98
3
0
c7
61
_g
1
C
ar
os
02
45
32
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
R
IN
G
-H
2_
fin
ge
r_
pr
ot
ei
n_
AT
L8
0-
lik
e)
0.
07
61
05
77
2
3.
31
68
78
85
2
1.
44
53
62
19
5
c1
28
49
_g
1
C
ar
os
00
13
21
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(a
rm
ad
ill
o_
re
pe
at
-c
on
ta
in
in
g_
pr
ot
ei
n_
8)
0.
03
43
02
60
9
2.
82
10
21
60
2
0.
06
20
71
65
1
c2
64
6_
g1
C
ar
os
00
43
41
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pu
ta
tiv
e_
co
ns
ta
ns
-li
ke
_p
ro
te
in
)
0.
15
18
97
13
9
2.
72
22
90
61
7
1.
21
03
42
39
c1
36
54
_g
1
C
ar
os
00
02
56
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_S
O
R
B
ID
R
A
FT
_0
6g
02
57
90
)
0.
14
54
96
53
9
2.
54
96
44
93
1
0.
10
99
52
79
9
c1
33
30
_g
1
C
ar
os
00
60
97
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(y
el
lo
w
_s
tri
pe
-li
ke
_t
ra
ns
po
rte
r_
12
)
0.
15
33
58
64
5
2.
50
87
91
75
0.
12
51
70
33
5
c1
03
62
_g
1
C
ar
os
00
96
69
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(p
ut
at
iv
e_
cy
tid
in
e_
de
am
in
as
e)
0.
18
53
92
16
9
2.
46
84
07
24
9
0.
36
50
00
16
4
c1
23
23
_g
1
C
ar
os
00
59
41
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0.
00
47
15
57
3
2.
42
83
33
08
8
0.
03
13
34
55
4
c8
86
0_
g1
C
ar
os
00
67
99
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
15
74
94
18
2.
36
13
38
08
8
0.
92
95
29
28
1
c9
08
4_
g1
C
ar
os
00
91
23
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(p
yr
uv
at
e_
de
ca
rb
ox
yl
as
e_
;_
Py
ru
va
te
_d
ec
ar
bo
xy
la
se
_[
EC
:4
.1
.1
.1
])
0.
02
48
98
52
6
2.
32
35
93
62
6
0.
34
96
06
98
6
c8
56
1_
g1
C
ar
os
00
96
32
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
15
91
50
6
2.
31
36
43
69
0.
35
18
33
24
8
c1
13
61
_g
1
C
ar
os
00
47
40
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_S
EL
M
O
D
R
A
FT
_4
35
79
)
0.
14
02
12
22
7
2.
27
77
79
40
2
0.
80
90
87
48
8
c1
32
21
_g
1
C
ar
os
00
68
63
.3
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
EI
N
3-
bi
nd
in
g_
F-
bo
x_
pr
ot
ei
n_
1-
lik
e)
0.
05
23
78
42
1
2.
25
06
44
03
5
0.
30
60
40
47
4
c9
50
2_
g1
C
ar
os
00
50
81
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
LI
TA
F-
do
m
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
)
0.
15
82
37
52
2.
24
40
08
55
6
0.
68
65
58
31
5
c1
02
97
_g
1
C
ar
os
00
55
96
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
)
0.
01
79
59
47
2.
09
01
97
22
2
0.
19
92
97
95
9
 105 
  
c8
67
3_
g1
C
ar
os
00
51
89
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
ch
ar
ac
te
riz
ed
_p
ro
te
in
)
0.
13
91
32
35
2.
00
46
47
73
3
0.
32
29
66
05
4
c7
07
7_
g1
C
ar
os
00
43
36
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
m
yb
-r
el
at
ed
_p
ro
te
in
_M
yb
4-
lik
e)
0.
19
03
45
90
2
1.
92
61
24
27
9
0.
19
04
71
23
9
c4
40
8_
g1
C
ar
os
01
75
05
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
06
77
63
98
3
1.
88
96
61
78
5
0.
81
69
63
94
6
c1
33
93
_g
1
C
ar
os
00
00
26
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(g
en
om
ic
_r
ef
er
en
ce
:S
L2
.4
0c
h0
1_
ge
ne
_r
eg
io
n:
79
30
93
71
-
79
31
06
64
_t
ra
ns
cr
ip
t_
re
gi
on
:S
L2
.4
0c
h0
1:
79
30
93
71
..7
93
10
66
4+
_g
o_
te
rm
s:
G
O
:0
00
48
42
_f
un
ct
io
na
l_
de
sc
rip
tio
n:
U
-b
ox
_d
om
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
_4
)
0.
01
49
00
31
6
1.
86
77
66
43
4
0.
07
09
00
35
6
c3
03
60
_g
1
C
ar
os
00
05
84
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
14
_k
D
a_
pr
ol
in
e-
ric
h_
pr
ot
ei
n_
D
C
2.
15
-li
ke
)
0.
05
99
89
25
6
1.
81
92
01
61
0.
31
91
65
44
7
c1
22
95
_g
1
C
ar
os
00
48
93
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
06
69
95
46
3
1.
74
32
97
09
4
0.
30
88
42
3
c1
30
92
_g
1
C
ar
os
00
23
14
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(h
ea
t_
sh
oc
k_
pr
ot
ei
n_
70
)
0.
13
39
31
23
6
1.
61
86
86
01
4
0.
19
08
47
65
5
c3
06
09
_g
1
C
ar
os
01
18
81
.2
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(S
-a
de
no
sy
lm
et
hi
on
in
e_
de
ca
rb
ox
yl
as
e_
uO
R
F)
0.
04
06
94
20
4
1.
52
15
59
64
7
1.
14
63
43
17
1
c5
75
9_
g1
C
ar
os
00
17
86
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ob
ab
le
_E
3_
ub
iq
ui
tin
-p
ro
te
in
_l
ig
as
e_
H
ER
C
1-
lik
e)
0
1.
50
79
68
06
9
0.
10
18
12
45
9
c1
12
22
_g
1
C
ar
os
01
60
27
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
12
43
80
70
8
1.
49
51
38
77
9
0.
03
13
38
68
6
c1
13
30
_g
1
C
ar
os
00
80
54
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
14
23
40
17
8
1.
46
97
72
68
2
0.
85
05
88
51
6
c1
06
28
_g
1
C
ar
os
00
32
38
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
09
18
47
35
9
1.
46
79
04
16
5
0.
36
05
21
59
7
c1
46
67
_g
1
C
ar
os
01
06
04
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(m
on
od
eh
yd
ro
as
co
rb
at
e_
re
du
ct
as
e;
_A
TM
D
A
R
4/
M
D
A
R
4;
_A
TM
D
A
R
4/
M
D
A
R
4_
(M
O
N
O
D
EH
Y
D
R
O
A
SC
O
R
B
AT
E_
R
E
D
U
C
TA
SE
_4
);_
m
on
od
eh
yd
ro
as
co
rb
at
e_
re
du
ct
as
e_
(N
A
D
H
)_
;_
K
08
23
2_
m
on
od
eh
yd
ro
as
co
rb
at
e_
re
du
ct
as
e_
(N
A
D
H
)_
[E
C
:1
.6
.5
.4
])
0.
01
97
42
73
3
1.
45
56
13
16
9
1.
07
81
07
13
3
c1
34
71
_g
1
C
ar
os
01
09
39
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
-1
)
0.
12
83
10
75
2
1.
41
98
28
32
5
0.
05
66
27
34
8
c1
47
04
_g
1
C
ar
os
00
57
84
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_O
sJ
_2
02
91
)
0.
06
00
14
14
7
1.
40
85
72
36
4
1.
84
68
45
42
2
c2
96
18
_g
1
C
ar
os
02
57
29
.1
__
(c
hr
om
06
)_
_(
m
R
N
A
)_
()
__
(c
on
se
rv
ed
_h
yp
ot
he
tic
al
_p
ro
te
in
)
0.
13
79
59
80
4
1.
38
82
13
93
5
1.
65
36
03
42
c1
16
55
_g
1
C
ar
os
00
03
42
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
11
22
11
24
6
1.
37
88
09
16
4
0.
46
03
83
87
6
c2
61
53
_g
1
C
ar
os
00
10
21
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(q
ui
no
ne
_r
ed
uc
ta
se
)
0.
13
01
70
71
6
1.
36
84
66
20
3
0.
91
52
69
96
1
c1
38
60
_g
1
C
ar
os
00
06
28
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
09
33
14
28
5
1.
36
55
94
23
4
0.
20
63
70
20
4
c1
31
84
_g
1
C
ar
os
00
32
14
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(D
D
B
1-
_a
nd
_C
U
L4
-a
ss
oc
ia
te
d_
fa
ct
or
)
0.
03
04
42
30
9
1.
33
78
27
37
6
0.
45
58
51
14
6
c1
29
18
_g
1
C
ar
os
01
54
30
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
()
__
(F
-b
ox
/k
el
ch
-r
ep
ea
t_
pr
ot
ei
n_
A
t3
g0
62
40
-li
ke
)
0.
06
63
61
24
9
1.
32
42
12
78
7
0.
00
64
44
84
7
c3
41
93
_g
1
C
ar
os
00
29
08
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
01
41
39
25
9
1.
31
55
70
61
2
0.
21
35
40
21
3
c1
04
72
_g
1
C
ar
os
00
13
30
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
00
17
83
26
3
1.
31
45
01
39
5
0.
13
49
91
55
7
c8
67
7_
g1
C
ar
os
00
29
19
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(D
N
A
-d
ire
ct
ed
_R
N
A
_p
ol
ym
er
as
e_
II
_s
ub
un
it_
R
PB
7)
0.
01
81
53
46
5
1.
26
46
76
22
3
0.
26
67
87
94
5
 106 
  
c4
27
2_
g1
C
ar
os
00
93
54
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
09
36
84
71
3
1.
24
59
24
80
4
0.
05
79
92
22
7
c1
40
56
_g
1
C
ar
os
00
19
32
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(h
yp
er
se
ns
iti
ve
-in
du
ce
d_
re
sp
on
se
_p
ro
te
in
_4
-li
ke
)
0.
09
76
08
04
2
1.
22
63
35
93
4
0.
18
92
88
02
3
c1
22
81
_g
1
C
ar
os
01
05
39
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
08
97
97
35
1.
22
56
47
20
5
0.
18
94
42
79
9
c1
50
57
_g
1
C
ar
os
00
46
32
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
09
73
78
08
2
1.
20
20
19
03
2
0.
99
96
26
07
6
c1
12
38
_g
1
C
ar
os
00
40
99
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(tr
an
sm
em
br
an
e_
9_
su
pe
rf
am
ily
_m
em
be
r_
3)
0.
06
13
32
29
9
1.
19
29
49
15
3
0.
32
43
73
53
2
c1
35
94
_g
1
C
ar
os
01
05
39
.2
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
00
16
56
42
1.
16
13
98
75
4
0.
30
09
99
53
1
c9
78
1_
g1
C
ar
os
02
07
59
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_A
R
A
LY
D
R
A
FT
_4
95
83
7)
0.
01
79
24
53
8
1.
15
60
68
01
7
0.
80
32
29
67
c1
35
57
_g
1
C
ar
os
00
88
77
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(C
ho
ris
m
at
e_
m
ut
as
e_
;_
C
ho
ris
m
at
e_
m
ut
as
e_
[E
C
:5
.4
.9
9.
5]
)
0.
02
72
67
63
7
1.
13
41
72
54
3
0.
36
72
90
7
c1
21
29
_g
1
C
ar
os
00
58
94
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(c
on
se
rv
ed
_h
yp
ot
he
tic
al
_p
ro
te
in
)
0.
00
42
67
89
2
1.
11
63
14
15
4
0.
09
72
91
84
7
c1
21
93
_g
1
C
ar
os
00
33
10
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
09
26
02
81
7
1.
11
08
33
65
6
0.
26
77
61
72
3
c9
75
0_
g1
C
ar
os
01
13
34
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
02
91
06
72
7
1.
10
92
41
62
6
0.
30
81
44
05
9
c1
35
55
_g
1
C
ar
os
00
12
57
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
10
57
19
87
1
1.
10
24
49
35
6
0.
65
47
51
77
4
c1
65
14
_g
1
C
ar
os
00
11
65
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
07
10
76
82
2
1.
10
04
06
36
1
2.
31
61
88
73
1
c1
04
65
_g
1
C
ar
os
02
66
78
.2
__
(c
hr
om
06
)_
_(
m
R
N
A
)_
()
__
(g
en
om
ic
_r
ef
er
en
ce
:S
L2
.4
0c
h0
8_
ge
ne
_r
eg
io
n:
33
17
51
-
33
27
34
_t
ra
ns
cr
ip
t_
re
gi
on
:S
L2
.4
0c
h0
8:
33
17
51
..3
32
73
4+
_g
o_
te
rm
s:
G
O
:0
00
82
70
_f
un
ct
io
na
l_
de
sc
rip
tio
n:
C
A
X
-in
te
ra
ct
in
g_
pr
ot
ei
n_
4)
0
1.
09
46
94
11
2
0.
07
74
34
34
8
c1
06
55
_g
1
C
ar
os
01
76
04
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
08
87
90
1
1.
09
14
33
99
3
0.
03
55
60
71
c1
41
67
_g
1
C
ar
os
01
37
71
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
ce
llu
lo
se
_s
yn
th
as
e)
0.
05
67
81
20
3
1.
07
74
82
83
3
0.
08
03
46
65
4
c9
15
2_
g1
C
ar
os
00
79
52
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
06
04
36
93
7
1.
07
33
17
31
9
1.
33
24
88
65
2
c7
53
9_
g1
C
ar
os
01
47
66
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
85
35
78
5
1.
07
29
25
81
7
0.
15
75
88
72
9
c1
17
97
_g
2
C
ar
os
00
56
95
.3
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_M
TR
_1
g1
10
37
0_
(H
ig
he
r_
sc
or
e_
or
th
ol
og
_w
ith
_u
nk
no
w
n_
fu
nc
tio
n:
_M
T6
G
00
86
60
_)
)
0.
00
73
86
73
7
1.
06
39
54
72
5
0.
21
03
96
08
5
c8
79
8_
g1
C
ar
os
01
36
74
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0.
03
89
78
09
3
1.
06
16
62
76
2
0.
40
59
21
83
3
c8
29
5_
g1
C
ar
os
00
09
65
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(p
ut
at
iv
e_
ge
rm
in
-li
ke
_p
ro
te
in
_2
-1
)
0.
03
54
70
12
3
1.
05
20
14
32
8
0.
01
48
59
36
3
c1
40
44
_g
1
C
ar
os
00
37
76
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(A
TP
as
e)
0.
00
43
27
58
3
1.
04
47
85
45
7
0.
25
64
46
46
c6
67
9_
g1
C
ar
os
00
78
20
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0.
00
23
57
78
7
1.
04
36
45
34
6
0.
16
26
14
80
6
c1
31
70
_g
1
C
ar
os
00
82
16
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(U
4/
U
6.
U
5_
tri
-s
nR
N
P-
as
so
ci
at
ed
_p
ro
te
in
)
0.
04
44
54
72
5
1.
04
08
00
23
6
0.
32
74
87
28
2
 107 
  
c1
13
00
_g
1
C
ar
os
00
04
67
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
07
76
95
04
1.
03
81
74
19
2
0.
53
70
88
31
7
c1
39
59
_g
1
C
ar
os
01
22
55
.4
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
03
57
60
86
1.
03
12
90
45
9
0.
37
53
78
39
7
c1
26
99
_g
1
C
ar
os
00
50
03
.3
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(m
at
e_
ef
flu
x_
fa
m
ily
_p
ro
te
in
)
0.
08
06
27
35
1.
02
93
39
84
0.
18
94
90
29
c1
04
24
_g
1
C
ar
os
01
86
80
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
02
13
24
13
1
1.
02
33
00
12
9
0.
00
79
76
74
9
c1
28
54
_g
1
C
ar
os
00
43
58
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
09
52
72
63
2
1.
02
13
33
86
1
0.
21
15
54
38
7
c7
42
4_
g1
C
ar
os
00
89
43
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
76
92
55
5
1.
02
08
21
30
6
0.
34
92
38
45
c9
63
0_
g2
C
ar
os
00
24
13
.3
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(U
bi
qu
iti
n_
do
m
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
)
0.
00
49
69
25
9
1.
01
83
96
51
3
0.
19
41
88
17
9
c1
24
77
_g
1
C
ar
os
00
43
89
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
03
24
85
69
1.
00
30
52
29
4
0.
57
43
21
58
9
c1
35
47
_g
1
C
ar
os
01
03
10
.2
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
0.
99
98
94
86
1
0.
19
62
20
85
2
c2
60
17
_g
1
C
ar
os
00
19
89
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0
0.
99
77
75
48
8
0.
02
75
06
82
c1
25
89
_g
1
C
ar
os
00
93
60
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(p
la
nt
_s
yn
ap
to
ta
gm
in
)
0.
07
54
20
70
9
0.
98
87
30
18
1
0.
46
29
55
06
6
c9
52
7_
g1
C
ar
os
00
18
80
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(O
s0
2g
04
75
30
0)
0
0.
97
99
63
03
4
0.
01
86
05
20
9
c8
96
2_
g1
C
ar
os
01
38
06
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(S
TM
1_
pr
ot
ei
n)
0
0.
97
81
19
60
5
0.
50
58
20
32
8
c1
29
27
_g
1
C
ar
os
00
54
31
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
82
30
46
2
0.
97
47
21
61
5
0.
08
69
47
8
c1
31
52
_g
1
C
ar
os
00
82
17
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
08
07
54
19
3
0.
96
71
17
74
3
0.
07
91
65
25
2
c1
04
95
_g
1
C
ar
os
00
81
62
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
02
80
57
98
2
0.
96
57
98
12
6
0
c1
42
08
_g
1
C
ar
os
00
30
79
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
06
04
36
93
7
0.
96
36
64
76
5
1.
27
57
26
04
4
c1
26
76
_g
1
C
ar
os
00
19
29
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(r
ec
ep
to
r_
ki
na
se
)
0
0.
95
97
57
46
7
0.
03
24
44
24
8
c1
35
38
_g
1
C
ar
os
00
66
79
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(G
Y
F_
do
m
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
)
0.
02
94
18
47
2
0.
95
92
19
63
2
0.
52
21
69
85
6
c8
88
4_
g1
C
ar
os
00
75
89
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(p
ro
te
in
_S
C
A
I_
is
of
or
m
_2
)
0.
04
40
75
21
4
0.
95
10
75
43
1
0.
09
89
58
61
7
c1
31
90
_g
1
C
ar
os
01
04
80
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
01
87
20
52
8
0.
94
36
10
25
2
0.
23
50
46
93
6
c1
28
13
_g
1
C
ar
os
00
71
76
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ob
ab
le
_m
et
hy
ltr
an
sf
er
as
e_
PM
T8
)
0.
07
94
18
61
2
0.
94
14
93
61
8
0.
29
80
12
06
5
c5
41
3_
g1
C
ar
os
00
40
88
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
cy
st
ei
ne
/h
is
tid
in
e-
ric
h_
C
1_
do
m
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
)
0
0.
94
14
51
16
7
0.
02
12
48
67
5
c6
49
2_
g1
C
ar
os
00
18
37
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
EI
D
1-
lik
e_
F-
bo
x_
pr
ot
ei
n_
2-
lik
e)
0.
00
85
95
47
5
0.
93
73
29
40
3
0.
15
56
29
2
 108 
  
c2
82
90
_g
1
C
ar
os
02
42
45
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
0.
93
71
57
1
0.
13
77
34
65
4
c1
24
40
_g
1
C
ar
os
00
63
74
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hi
gh
_m
ob
ili
ty
_g
ro
up
_f
am
ily
)
0.
02
36
89
78
7
0.
93
33
62
96
0.
24
90
58
50
8
c8
01
7_
g1
C
ar
os
00
15
95
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(p
ol
yg
al
ac
tu
ro
na
se
-li
ke
_p
ro
te
in
-li
ke
)
0.
09
19
01
45
0.
92
79
17
37
3
0.
26
25
33
64
3
c1
30
39
_g
1
C
ar
os
00
50
21
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
08
76
33
55
8
0.
92
75
04
61
9
0.
27
02
19
03
3
c2
63
28
_g
1
C
ar
os
01
56
89
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
()
__
(F
er
ric
-c
he
la
te
_r
ed
uc
ta
se
)
0.
04
66
78
20
7
0.
92
22
58
50
3
0.
09
21
86
26
3
c8
76
1_
g1
C
ar
os
01
58
03
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
to
no
pl
as
t_
in
tri
ns
ic
_p
ro
te
in
)
0.
00
38
20
21
1
0.
92
17
20
28
4
2.
62
88
57
19
5
c3
34
38
_g
1
C
ar
os
00
70
08
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_S
O
R
B
ID
R
A
FT
_0
3g
00
38
10
)
0.
00
76
40
42
3
0.
92
12
81
43
6
1.
00
58
70
45
6
c1
15
89
_g
1
C
ar
os
00
14
71
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(is
oc
ho
ris
m
at
e_
sy
nt
ha
se
_;
_I
so
ch
or
is
m
at
e_
sy
nt
ha
se
_[
EC
:5
.4
.4
.2
])
0.
05
49
60
30
6
0.
91
91
32
44
0.
33
99
99
31
7
c1
10
62
_g
1
C
ar
os
01
42
00
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(g
en
om
ic
_r
ef
er
en
ce
:S
L2
.4
0c
h0
3_
ge
ne
_r
eg
io
n:
97
45
19
3-
97
45
95
7_
tra
ns
cr
ip
t_
re
gi
on
:S
L2
.4
0c
h0
3:
97
45
19
3.
.9
74
59
57
-
_f
un
ct
io
na
l_
de
sc
rip
tio
n:
G
en
om
ic
_D
N
A
_c
hr
om
os
om
e_
5_
TA
C
_c
lo
ne
_K
1F
13
)
0
0.
91
51
49
58
2
0.
03
01
36
78
5
c1
33
09
_g
1
C
ar
os
00
45
93
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
se
rin
e/
th
re
on
in
e-
pr
ot
ei
n_
ki
na
se
_O
X
I1
-li
ke
)
0.
00
68
49
86
5
0.
90
34
19
22
8
0.
25
70
31
75
7
c8
13
6_
g1
C
ar
os
00
72
36
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(p
ro
ba
bl
e_
pr
ot
ei
n_
ph
os
ph
at
as
e_
2C
_4
3)
0.
04
98
87
55
3
0.
90
21
22
70
3
0.
72
04
49
90
1
c4
09
7_
g1
C
ar
os
00
34
08
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(p
ut
at
iv
e_
pt
er
in
-4
-a
lp
ha
-c
ar
bi
no
la
m
in
e_
de
hy
dr
at
as
e_
is
of
or
m
_1
)
0.
06
03
77
24
6
0.
90
15
00
30
3
0.
44
56
06
28
c1
17
62
_g
1
C
ar
os
01
06
19
.2
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
05
12
66
93
7
0.
90
05
37
77
7
0.
27
75
12
48
2
c6
08
5_
g1
C
ar
os
00
62
69
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0
0.
88
53
16
34
0.
06
40
86
58
1
c2
21
13
_g
1
C
ar
os
00
50
53
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(a
cy
l-p
ro
te
in
_t
hi
oe
st
er
as
e_
2-
lik
e)
0.
00
89
16
31
3
0.
88
53
01
47
8
0.
91
91
63
55
9
c1
14
19
_g
1
C
ar
os
01
95
13
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
()
__
(z
in
c_
fin
ge
r_
C
C
C
H
_d
om
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
_3
-li
ke
)
0
0.
88
25
13
02
8
1.
09
09
77
55
1
c1
24
67
_g
1
C
ar
os
00
03
11
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(O
s0
8g
02
30
50
0)
0.
08
70
59
03
4
0.
88
23
04
62
0.
12
56
53
43
2
c1
27
41
_g
1
C
ar
os
01
40
40
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0.
07
62
32
61
5
0.
88
17
09
85
7
0.
14
00
02
70
7
c8
17
6_
g1
C
ar
os
00
23
61
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
03
52
84
72
5
0.
88
16
32
80
5
0.
14
20
22
32
8
c8
68
8_
g1
C
ar
os
01
10
46
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
ch
ar
ac
te
riz
ed
_p
ro
te
in
_L
O
C
10
08
53
35
5)
0.
01
49
67
46
9
0.
87
89
04
44
6
0.
80
60
49
59
2
c1
05
81
_g
1
C
ar
os
02
82
24
.1
__
(c
hr
om
06
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
m
ul
tip
le
_C
2_
an
d_
tra
ns
m
em
br
an
e_
do
m
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
_2
-li
ke
)
0.
03
61
72
62
6
0.
87
75
55
8
0.
00
39
68
35
4
c4
99
_g
1
C
ar
os
01
02
32
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_R
C
O
M
_1
40
73
60
)
0.
00
53
49
78
8
0.
87
27
62
43
4
0.
15
21
48
62
2
c8
62
3_
g1
C
ar
os
00
00
79
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
ch
ol
in
e/
et
ha
no
la
m
in
e_
ki
na
se
)
0.
05
55
94
52
0.
86
96
83
24
2
0.
15
56
33
37
7
c1
35
16
_g
1
C
ar
os
00
86
77
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(A
P2
_d
om
ai
n-
co
nt
ai
ni
ng
_t
ra
ns
cr
ip
tio
n_
fa
ct
or
)
0.
04
47
68
10
1
0.
86
44
64
21
5
0.
10
02
95
48
3
 109 
  
c1
25
76
_g
1
C
ar
os
00
57
83
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(p
ro
ba
bl
e_
LR
R
_r
ec
ep
to
r-l
ik
e_
se
rin
e/
th
re
on
in
e-
pr
ot
ei
n_
ki
na
se
_A
t1
g5
61
40
-li
ke
)
0.
00
28
65
15
8
0.
86
44
32
10
8
0.
18
16
67
39
8
c7
57
4_
g1
C
ar
os
00
31
09
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pu
ta
tiv
e_
pe
pt
id
yl
-tR
N
A
_h
yd
ro
la
se
_P
TR
H
D
1-
lik
e)
0
0.
85
46
69
84
4
0.
30
73
50
43
5
c1
15
17
_g
1
C
ar
os
00
97
24
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_V
IT
IS
V
_0
22
65
0)
0.
04
71
25
88
8
0.
85
39
38
25
1
0.
28
11
58
82
5
c7
27
_g
1
C
ar
os
00
97
11
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0.
04
58
32
34
4
0.
85
28
87
77
7
0.
23
32
07
69
6
c1
02
18
_g
1
C
ar
os
01
54
60
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ob
ab
le
_s
er
in
e/
th
re
on
in
e-
pr
ot
ei
n_
ki
na
se
_A
t1
g1
83
90
-li
ke
)
0.
02
72
56
31
2
0.
84
60
18
49
6
0.
14
33
83
07
3
c6
86
1_
g1
C
ar
os
01
23
36
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
69
50
18
5
0.
84
58
52
03
7
0.
04
56
12
04
8
c7
24
9_
g1
C
ar
os
00
75
49
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
ho
m
eo
bo
x-
le
uc
in
e_
zi
pp
er
_p
ro
te
in
_H
AT
5-
lik
e)
0.
04
38
48
24
6
0.
84
54
37
23
8
0.
28
91
66
00
2
c3
52
2_
g1
C
ar
os
01
30
49
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(O
s0
5g
03
04
10
0)
0
0.
84
49
80
20
1
0.
09
29
58
94
7
c1
07
49
_g
1
C
ar
os
01
23
46
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
ni
tra
te
_t
ra
ns
po
rte
r_
1.
2-
lik
e)
0
0.
83
77
49
64
4
0.
28
48
10
25
1
c1
18
04
_g
1
C
ar
os
01
81
30
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
30
59
15
4
0.
83
71
23
55
6
0.
34
06
96
29
9
c6
73
2_
g1
C
ar
os
00
86
20
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
R
ab
G
A
P/
TB
C
_d
om
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
)
0.
06
23
38
97
8
0.
83
41
28
02
9
0.
21
97
99
73
4
c1
56
02
_g
1
C
ar
os
00
39
64
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
03
77
69
35
5
0.
83
37
01
35
9
0.
14
80
59
15
5
c1
82
44
_g
1
C
ar
os
00
17
86
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ob
ab
le
_E
3_
ub
iq
ui
tin
-p
ro
te
in
_l
ig
as
e_
H
ER
C
1-
lik
e)
0
0.
83
33
33
33
3
0.
00
57
60
10
7
c9
20
6_
g1
C
ar
os
00
94
44
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_M
TR
_3
g0
91
28
0)
0.
00
71
33
05
1
0.
83
21
70
83
5
0.
84
32
57
28
9
c1
18
54
_g
1
C
ar
os
00
78
82
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0
0.
82
61
41
20
3
0.
34
83
20
44
2
c3
35
18
_g
1
C
ar
os
00
77
81
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
13
35
58
2
0.
81
73
66
22
3
0.
30
02
13
91
3
c8
92
1_
g1
C
ar
os
01
07
30
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_V
IT
IS
V
_0
19
34
3)
0
0.
80
35
47
77
0.
04
95
10
13
8
c9
15
5_
g1
C
ar
os
00
59
69
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
0.
80
28
31
26
2
0.
10
04
77
38
4
c1
17
00
_g
2
C
ar
os
00
16
60
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(S
er
in
e_
ca
rb
ox
yp
ep
tid
as
e-
lik
e_
pr
ot
ei
n)
0.
03
13
30
21
0.
80
27
33
65
8
0.
23
60
94
21
9
c1
09
93
_g
1
C
ar
os
00
89
46
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
02
27
84
72
9
0.
80
19
85
70
4
0.
10
80
36
06
3
c1
13
36
_g
1
C
ar
os
00
70
06
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_O
sJ
_3
08
44
)
0.
03
75
75
36
0.
78
78
66
47
4
0.
07
83
97
24
c1
24
13
_g
1
C
ar
os
00
79
01
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(e
lo
ng
at
io
n_
fa
ct
or
_P
)
0.
01
14
00
94
3
0.
78
50
05
71
9
0.
15
07
59
52
5
c1
42
10
_g
2
C
ar
os
01
08
06
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
m
ito
ch
on
dr
ia
l_
in
ne
r_
m
em
br
an
e_
pr
ot
ea
se
_s
ub
un
it_
2-
lik
e)
0.
00
17
16
11
1
0.
78
33
07
68
5
0.
36
32
59
12
6
c1
27
82
_g
1
C
ar
os
00
90
02
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ot
ei
n_
N
SP
-I
N
TE
R
A
C
TI
N
G
_K
IN
A
SE
_1
-li
ke
)
0.
00
08
28
21
0.
78
11
96
76
7
0.
30
54
84
29
 110 
  
c1
07
48
_g
1
C
ar
os
00
16
93
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
06
18
39
67
1
0.
77
91
01
23
5
0.
74
93
62
34
2
c1
31
69
_g
1
C
ar
os
01
55
52
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
07
03
38
82
1
0.
77
59
27
66
1
0.
07
84
99
50
6
c1
43
94
_g
1
C
ar
os
00
94
94
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
zi
nc
_f
in
ge
r_
C
C
C
H
_d
om
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
_4
8-
lik
e)
0.
01
31
84
20
6
0.
77
56
36
50
9
0.
32
86
10
74
c1
05
16
_g
1
C
ar
os
00
66
90
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
04
24
77
46
7
0.
77
32
20
30
1
0.
15
18
15
87
9
c2
32
_g
1
C
ar
os
00
16
50
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
un
kn
ow
n)
0.
05
49
60
30
6
0.
77
31
59
92
8
0.
32
99
34
11
7
c1
42
77
_g
1
C
ar
os
01
29
33
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(a
rm
ad
ill
o_
re
pe
at
-c
on
ta
in
in
g_
ki
ne
si
n-
lik
e_
pr
ot
ei
n_
2-
lik
e)
0.
06
82
25
13
2
0.
77
22
78
96
4
0.
45
04
00
50
7
c3
52
91
_g
1
C
ar
os
01
20
32
.2
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_A
R
A
LY
D
R
A
FT
_3
13
96
8)
0.
00
23
57
78
7
0.
77
17
01
62
0.
05
58
25
54
9
c2
78
38
_g
1
C
ar
os
00
74
10
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
02
61
74
41
7
0.
76
97
22
91
0.
57
86
16
40
2
c4
46
3_
g1
C
ar
os
00
39
01
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
0.
76
92
80
46
8
0
c2
50
9_
g1
C
ar
os
00
78
41
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(b
et
a-
ga
la
ct
os
id
as
e_
(E
C
:3
.2
.1
.2
3)
)
0
0.
76
86
76
12
8
0.
00
24
92
05
1
c2
95
52
_g
1
C
ar
os
02
05
96
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
()
__
(f
or
m
at
e_
de
hy
dr
og
en
as
e_
;_
fo
rm
at
e_
de
hy
dr
og
en
as
e_
[E
C
:1
.2
.1
.2
])
0.
06
75
69
98
7
0.
76
81
94
34
4
1.
11
19
28
09
3
c1
00
01
_g
1
C
ar
os
00
00
82
.2
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
04
20
29
78
6
0.
76
75
20
06
7
0.
35
02
60
42
4
c1
03
01
_g
1
C
ar
os
01
31
33
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pu
ta
tiv
e_
di
se
as
e_
re
si
st
an
ce
_p
ro
te
in
)
0.
00
88
84
55
4
0.
76
69
98
70
8
0.
20
38
50
91
9
c1
28
05
_g
1
C
ar
os
01
24
16
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
rib
os
om
al
_R
N
A
-p
ro
ce
ss
in
g_
pr
ot
ei
n_
8)
0.
06
50
25
66
7
0.
76
64
25
27
3
0.
58
88
37
13
c1
57
15
_g
1
C
ar
os
02
11
89
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
po
ly
(r
C
)-
bi
nd
in
g_
pr
ot
ei
n_
3-
lik
e)
0
0.
76
32
12
13
0.
42
68
80
21
9
c6
74
1_
g1
C
ar
os
02
91
71
.1
__
(c
hr
om
06
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
C
ST
_c
om
pl
ex
_s
ub
un
it_
C
TC
1)
0.
03
52
84
72
5
0.
76
28
90
75
0.
00
63
02
68
c2
46
_g
1
C
ar
os
02
64
25
.1
__
(c
hr
om
06
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
0.
76
19
82
03
0.
04
11
86
13
5
c1
10
54
_g
1
C
ar
os
00
17
00
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(W
D
_r
ep
ea
t_
do
m
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
_8
3-
lik
e_
(H
ig
he
r_
sc
or
e_
or
th
ol
og
_w
ith
_u
nk
no
w
n_
fu
nc
tio
n:
_M
T8
G
09
26
20
_)
)
0.
06
48
11
58
2
0.
75
76
90
23
7
0.
11
43
89
65
1
c1
27
66
_g
2
C
ar
os
01
15
79
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(A
m
m
on
iu
m
_t
ra
ns
po
rte
r)
0.
00
34
39
68
2
0.
75
42
91
28
0.
44
13
10
07
4
c3
46
0_
g1
C
ar
os
02
53
02
.1
__
(c
hr
om
06
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
04
25
44
61
9
0.
75
33
36
60
1
0
c1
13
77
_g
1
C
ar
os
00
42
05
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
05
42
58
93
9
0.
75
23
83
99
0.
03
59
94
40
3
c1
32
38
_g
1
C
ar
os
00
52
06
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
06
45
12
86
3
0.
75
06
81
06
4
0.
20
10
14
62
8
c5
91
8_
g1
C
ar
os
01
41
47
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pe
nt
at
ric
op
ep
tid
e_
re
pe
at
-c
on
ta
in
in
g_
pr
ot
ei
n)
0
0.
74
47
28
67
2
0.
01
06
62
19
1
c3
33
68
_g
1
C
ar
os
01
24
39
.2
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(g
en
om
ic
_r
ef
er
en
ce
:S
L2
.4
0c
h0
7_
ge
ne
_r
eg
io
n:
59
67
28
73
-5
96
73
30
7_
tra
ns
cr
ip
t_
re
gi
on
:S
L2
.4
0c
h0
7:
59
67
28
73
..5
96
73
30
7-
_f
un
ct
io
na
l_
de
sc
rip
tio
n:
G
en
om
ic
_D
N
A
_c
hr
om
os
om
e_
3_
TA
C
_c
lo
ne
_K
7L
4)
0
0.
74
41
88
70
9
0.
02
10
92
44
 111 
  
c3
53
8_
g1
C
ar
os
00
84
85
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
zi
nc
_f
in
ge
r_
C
C
C
H
_d
om
ai
n-
co
nt
ai
ni
ng
_p
ro
te
in
_4
4-
lik
e)
0
0.
74
17
23
98
8
0.
01
99
29
40
9
c1
29
48
_g
1
C
ar
os
00
63
49
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_V
IT
IS
V
_0
30
96
1)
0.
00
31
18
84
4
0.
74
10
71
58
7
0.
11
29
15
21
9
c1
14
41
_g
1
C
ar
os
01
53
83
.2
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
00
43
27
58
3
0.
74
05
18
89
5
0.
18
70
79
43
9
c3
46
00
_g
1
C
ar
os
00
52
52
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
G
TP
-b
in
di
ng
_p
ro
te
in
_A
t2
g2
28
70
-li
ke
)
0.
00
38
87
36
3
0.
74
02
01
38
6
0.
12
56
83
23
7
c9
57
9_
g1
C
ar
os
00
05
53
.3
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(Z
in
c_
fin
ge
r_
pr
ot
ei
n_
C
O
N
ST
A
N
S-
lik
e_
pr
ot
ei
n)
0.
05
45
79
77
7
0.
73
79
81
26
1.
78
83
45
99
3
c1
18
14
_g
1
C
ar
os
00
62
87
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
02
85
91
89
4
0.
73
58
03
82
1
0.
21
51
14
9
c1
33
66
_g
1
C
ar
os
00
15
07
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
hy
po
th
et
ic
al
_p
ro
te
in
_S
EL
M
O
D
R
A
FT
_4
38
02
0)
0.
02
41
97
15
9
0.
73
53
94
66
8
1.
04
56
40
22
1
c9
64
5_
g1
C
ar
os
01
30
79
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_V
IT
IS
V
_0
38
18
1)
0.
05
73
77
78
3
0.
72
98
25
51
7
0.
12
12
76
86
6
c1
09
75
_g
1
C
ar
os
00
05
70
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(U
D
P-
gl
yc
os
yl
tra
ns
fe
ra
se
_9
2A
1-
lik
e)
0.
04
94
37
80
5
0.
72
75
13
83
9
0.
03
33
42
13
3
c4
06
_g
1
C
ar
os
01
17
26
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(G
A
G
A
-b
in
di
ng
_t
ra
ns
cr
ip
tio
na
l_
ac
tiv
at
or
)
0.
00
73
27
04
6
0.
72
32
82
49
9
0.
31
53
72
48
2
c6
23
5_
g1
C
ar
os
00
37
92
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
D
O
G
1_
al
ph
a_
sp
lic
e_
va
ria
nt
)
0.
03
86
57
25
5
0.
72
28
57
16
9
0
c1
10
36
_g
1
C
ar
os
00
58
49
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(c
on
se
rv
ed
_h
yp
ot
he
tic
al
_p
ro
te
in
)
0.
00
19
77
25
8
0.
72
27
16
41
8
0.
22
47
07
44
7
c1
41
60
_g
1
C
ar
os
00
69
53
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
03
73
61
27
5
0.
71
75
13
39
8
0.
18
90
93
74
6
c3
93
9_
g1
C
ar
os
00
52
14
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
05
66
83
87
8
0.
71
68
56
25
8
0.
57
63
44
15
4
c8
12
8_
g1
C
ar
os
01
67
53
.2
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
AT
P-
de
pe
nd
en
t_
R
N
A
_h
el
ic
as
e_
db
p9
)
0.
01
21
82
71
8
0.
71
22
89
57
7
0.
14
68
03
35
4
c1
05
01
_g
1
C
ar
os
00
79
45
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(C
O
N
ST
A
N
S_
in
te
ra
ct
in
g_
pr
ot
ei
n_
4)
0.
00
95
50
52
8
0.
71
21
79
56
3
0.
24
90
02
91
4
c8
03
8_
g1
C
ar
os
00
44
44
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(D
EA
D
-b
ox
_A
TP
-d
ep
en
de
nt
_R
N
A
_h
el
ic
as
e_
30
-li
ke
)
0.
06
22
05
70
2
0.
71
08
28
43
9
0.
17
83
52
42
9
c1
11
92
_g
1
C
ar
os
01
29
43
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(c
on
se
rv
ed
_h
yp
ot
he
tic
al
_p
ro
te
in
)
0.
00
59
24
31
2
0.
71
02
60
44
7
0.
19
03
76
11
3
c1
42
8_
g1
C
ar
os
00
10
42
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0
0.
70
98
89
26
5
0.
03
34
23
28
4
c1
35
05
_g
1
C
ar
os
01
00
32
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(g
lu
ta
m
at
e-
ric
h_
W
D
_r
ep
ea
t-c
on
ta
in
in
g_
pr
ot
ei
n_
1-
lik
e)
0.
05
63
31
89
0.
70
68
87
80
9
0.
38
54
15
86
3
c1
06
56
_g
1
C
ar
os
01
01
80
.3
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
()
__
(D
B
P1
;_
D
bp
1p
_;
_K
11
59
4_
AT
P-
de
pe
nd
en
t_
R
N
A
_h
el
ic
as
e_
be
l_
[E
C
:3
.6
.1
.-]
)
0.
03
49
63
88
7
0.
70
66
26
10
2
0.
23
08
04
48
8
c1
54
16
_g
1
C
ar
os
00
62
03
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(L
a_
pr
ot
ei
n_
1)
0.
05
83
32
83
6
0.
70
64
56
27
5
0.
46
97
03
89
3
c1
25
43
_g
1
C
ar
os
00
98
79
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(T
AT
A
-b
in
di
ng
_p
ro
te
in
-a
ss
oc
ia
te
d_
fa
ct
or
_1
72
-li
ke
)
0.
01
67
37
95
3
0.
70
14
94
15
5
0.
31
18
56
68
2
c1
42
66
_g
3
C
ar
os
00
89
13
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
()
__
(h
yp
ot
he
tic
al
_p
ro
te
in
_O
sJ
_0
71
17
)
0.
03
42
62
52
0.
69
51
47
57
1
0.
26
53
00
63
8
 112 
  
c2
44
43
_g
1
C
ar
os
01
61
15
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
01
73
71
45
0.
69
47
44
83
2
0
c1
31
58
_g
1
C
ar
os
00
84
69
.1
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
try
ps
in
-li
ke
_p
ro
te
in
)
0.
04
98
64
20
3
0.
69
46
57
10
9
0.
18
76
12
21
8
c1
15
62
_g
1
C
ar
os
00
25
09
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(M
U
T9
-r
el
at
ed
_s
er
in
e/
th
re
on
in
e_
pr
ot
ei
n_
ki
na
se
)
0.
00
92
96
84
2
0.
69
34
35
58
1
0.
21
44
18
33
7
c1
33
50
_g
3
C
ar
os
02
04
39
.1
__
(c
hr
om
05
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
06
66
82
08
7
0.
69
09
69
30
4
0.
11
13
44
96
9
c2
99
9_
g1
C
ar
os
00
43
76
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
la
te
_e
m
br
yo
ge
ne
si
s_
ab
un
da
nt
_p
ro
te
in
)
0.
05
34
18
77
4
0.
68
99
90
78
1
0.
72
26
75
15
4
c1
30
08
_g
1
C
ar
os
00
56
72
.2
__
(c
hr
om
02
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
03
14
64
51
4
0.
68
42
62
10
4
0.
79
13
22
74
c1
41
54
_g
1
C
ar
os
00
08
57
.1
__
(c
hr
om
01
)_
_(
m
R
N
A
)_
()
__
(g
en
om
ic
_r
ef
er
en
ce
:S
L2
.4
0c
h0
2_
ge
ne
_r
eg
io
n:
13
90
60
95
-1
39
08
49
1_
tra
ns
cr
ip
t_
re
gi
on
:S
L2
.4
0c
h0
2:
13
90
60
95
..1
39
08
49
1-
_g
o_
te
rm
s:
G
O
:0
00
55
15
_f
un
ct
io
na
l_
de
sc
rip
tio
n:
H
et
er
og
en
eo
us
_n
uc
le
ar
_r
ib
on
uc
le
op
ro
te
in
_A
3-
lik
e_
p)
0.
02
92
33
57
0.
68
37
60
07
9
0.
73
68
30
21
6
c8
51
3_
g1
C
ar
os
01
48
88
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
pr
ed
ic
te
d_
pr
ot
ei
n)
0.
00
31
18
84
4
0.
68
33
25
97
3
0.
15
72
82
40
4
c2
40
29
_g
1
C
ar
os
01
03
79
.1
__
(c
hr
om
03
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
F1
6A
14
.2
1)
0.
04
26
04
31
0.
67
98
52
26
8
0.
12
65
56
68
2
c9
20
9_
g1
C
ar
os
01
61
49
.1
__
(c
hr
om
04
)_
_(
m
R
N
A
)_
(n
/a
)_
_(
N
o_
hi
ts
_f
ou
nd
)
0.
03
36
87
99
6
0.
67
18
05
80
8
0.
29
30
51
27
1
 113 
    
Table 10. RT-PCR primers for investigation of tissue-specific gene expression
Primer name Primer sequence
T16H2-F GATCAACTCACAGTGGCAGTC
T16H2-R GACTTGAGGACTTGTGATTGGC
PCR-60S-F TCTTAGTTGGAATGTTCAGCACCTG
PCR-60S-R CAAGGTTGGAGCCCCTGCTCGTGTT
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Table 11. RT-PCR primers for investigation of gene expression in FACS samples
Primer name Primer sequence
TDC-RT01 CGCCTGTATATGTCCCGAGT
TDC-RT02 GTTGCGATTTGCCAATTTTT
STR-RT01 ACCATTGTGTGGGAGGACAT
STR-RT02 CCATTTGAATGGCACTCCTT
SGD-RT01 ATTTGCACCAGGAAGAGGTG
SGD-RT02 TATGAACCATCCGAGCATGA
T16H-RT01 GCTTCATCCACCAGTTCCAT
T16H-RT02 CCGGACATATCCTTCTTCCA
D4H-RT01 TTGACATTTGGGACAAGCAA
D4H-RT02 CCAAAAGCAACAGCAACAGA
DAT-RT01 CTTCTTCTCATCACGTACCAACTC
DAT-RT02 ATACCAAACTCAACGGCCTTAG
PRX1-RT01 TAGCTCAAACAACTCGGCCACC
PRX1-RT02 GCAGCACTGATGAATCGCACC
RPS9-RT01 AGCGCCGCCTTCAAACCCTT
RPS9-RT02 GCCAGGACGACCACCACCGA
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General discussion and concluding remarks : 
TIA biosynthesis mechanism in Catharanthus roseus plant 
 
TIA localization in C. roseus stem and leaf tissues.  
In the present study, metabolome analyses using Imaging MS and Single-cell MS 
revealed that most TIAs and strictosidine localized in idioblast cells and laticifer cells in 
C. roseus (Yamamoto et al., 2016). Strictosidine is well known as a central precursor of 
all TIAs. Thus far, it has been supposed that strictosidine is produced in the vacuole of 
epidermal cells and subsequent biosynthesis from strictosidine also occurs in the 
nucleus of the epidermal cells (Thamm et al., 2016). Present results showed that 
strictosidine also localized in both idioblast cells and laticifer cells. My results 
suggested that both idioblast cell and laticifer cell play important roles not only for 
accumulation of TIAs end products but also for temporary accumulation of TIAs 
intermediates or/and strictosidine biosynthesis (Fig. 12). Furthermore, according to TIA 
intermediates localized in C. roseus idioblast cell and laticifer cell, it might be possible 
that TIA biosynthesis related genes are expressed in these types of cells, such as 
homologous genes of strictosidine synthase, strictosidine β-glucosidase or subsequent 
TIA biosynthesis enzymes. If these TIAs intermediates are produced in only the 
epidermal cells as suggested before, these intermediates must be needed to be 
transported from idioblast cells and laticifer cells to epidermal cells when these 
substances are used for subsequent TIA biosynthesis. It is the high possibility that 
idioblast cell and laticifer cell also have transporters of TIA intermediates, such as 
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strictosidine transporters. Recent investigation revealed that ABC transporter of C. 
roseus (CrTPT2) transports catharanthine from the epidermal cell to wax layer (Yu et 
al., 2013). This is the only detected C. roseus TIA transporter so far. Recent 
investigation also suggested that further ABC transporter and H+ antiport system are 
related to TIA metabolism in C. roseus. (Carqueijeiro et al., 2013). Since catharanthine 
and other TIA intermediates were accumulated both in the idioblast cell and laticifer 
cell, it is the possibility that other catharanthine and TIA transporters might localize in 
idioblast cell and laticifer cell. 
 
Vindoline is mainly produced in C. roseus leaf tissues.  
When I investigate the metabolite distribution in stem idioblast cell and laticifer cell by 
using Single-cell MS, I could not detect any vindoline and vindoline intermediates in 
these cells. However, when I investigated metabolites in leaf idioblast cell and laticifer 
cell by the same method, both vindoline and vindoline intermediates were localized in 
those cells. Furthermore, I investigated vindoline content in laticifer cells of each tissue, 
i.e. leaf tissue, leaf primordium and stem tissue. This result showed that vindoline 
accumulated in leaf tissues and vindoline content in laticifer cells increased as leaf 
expanded (Fig. 27). It is important that vindoline biosynthesis pathway is supported by 
the development of cells surrounding laticifer cells. Especially, it is suggested that 
epidermal cells are deeply involved in this vindoline biosynthesis because Tabersonine 
16-hydroxylase 2 (T16H2) are expressed in the epidermal cells of leaf tissues (Besseau 
et al., 2013). T16H2 enzyme is known as a key enzyme to coordinate between vindoline 
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and vindorosine pathways (Besseau et al., 2013). Down-regulation of T16H2 led to 
decrease 16-hydroxytabersonine, deacetylvindoline and vindoline contents. On the other 
hand, this down-regulation increased deacetylvindorosine and vindorosine contents 
(Besseau et al., 2013). I also obtained similar expression data of T16H2 in C. roseus 
stem and leaf tissues (Fig. 22). From these results and reports, it is suggested that 
T16H2 act as a coordinator of vindoline and vindorosine pathway in those tissues. 
Investigaton on the regulatory factor of T16H2 will lead to reveal how and when 
vindoline pathway is activated. 
 
Transcriptional regulation of metabolism and differentiation in idioblast cell and 
laticifer cell.  
TIA metabolism is also regulated by plant hormones, such as jasmonate and salicylic 
acid, in C. roseus. These days, it has been revealed the complicated transcriptional 
regulation involved in iridoid and TIA biosynthesis in C. roseus (Pan et al., 2016). 
ORCA2 and ORCA3, that is AP2/ERF family transcription factors, regulate the 
expression of TIA enzymes such as strictosidine synthase (STR) and 
desacetoxyvindoline 4-hydroxylase (D4H) (Van Der Fits et al., 2000). BIS1 and BIS2, 
those are the bHLH transcription factors, control the iridoid biosynthetic pathway (Van 
Moerkercke et al., 2015; Van Moerkercke et al., 2016). Zinc finger–binding protein 
genes (ZCTs) and CrMYC also regulate TIA biosynthesis complicatedly (Pan et al., 
2016). 
 Although it has been that several transcription factors affect the expression of 
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TIA biosynthetic enzymes localized in idioblast cells and laticifer cells, it has been still 
unknown how the lipid biosynthesis and serpentine biosynthesis were regulated. Lipid 
and serpentine biosynthesis are important characteristics of idioblast cells and laticifer 
cells. If I can reveal the transcriptional regulation of lipid biosynthesis and additional 
TIA biosynthesis, these results would lead us to understand how idioblast cells and 
laticifer cells are differentiated (Fig. 28). 
 
Iridoids have the role for protection against insects.  
Iridoid is one of monoterpenoid produced from IPP and these compounds are 
glycosylated usually. It is believed that over 50 plants families produce iridoid 
glycosides (Lampert et al., 2010). Iridoids are well known as defense compounds that 
were used not only plants but also insects. Some butterflies utilize plant iridoid to 
protect against vertebrate (gray jay) and invertebrate predators (ants and spiders) 
(Nishida, 2002). Our results showed that iridoids including loganin and secologanin 
localized in epidermal cell in stem and leaf tissues (Yamamoto et al., 2016). It is a 
suitable distribution of iridoids to protect themselves from predators. I consider that 
these iridoids localized in epidermal cells will have the biological activities for 
protection against predators (Figs. 3 and 17), but that mechanism has still been 
unknown. 
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The role of idioblast cells and laticifer cells.  
Idioblast cell and laticifer cell differed in their form, size, contents, and cell structure, 
compared with common cell types such as parenchyma cell or epidermal cell (Foster, 
1956) (Figs. 3L, 4 and 15). In C. roseus, idioblast cells and laticifer cells were classified 
as plant idioblasts using the broad definition of this cell type. PCA also showed that 
idioblast cell and laticifer cell have many similar features (Fig. 10), which imply that 
these cell types play a similar role in plant (Hagel et al., 2008). The physiological 
differences between idioblast cells and laticifer cells remain unclear. 
 In this study, I revealed the localization of iridoids and TIAs in C. roseus stem 
and leaf tissues. Although iridoids, including loganin and secologanin, localized and 
accumulated in epidermal cells, most of TIAs localized in idioblast cells and laticifer 
cells. These data help us to investigate which metabolic systems are progressed in the 
idioblast cells and laticifer cells in this plant. The number of latex containing plants is 
estimated to be about 12,500 and latex synthesis might be related to specialized 
metabolism. Although some reports latex metabolites benefits plant under herbivore 
attack (Huber et al., 2016), it is poorly understood why those special secretory idioblasts 
are needed in plant life. In the near future, I would like to know the relationship 
between specialized metabolism and secretory idioblasts in plants. 
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Figure 
 
Fig. 27. TIA localization in laticifer cells in each tissue. (A) Vindoline. (B) 
Demethoxyvindoline. (C) Serpentine. Vindoline is accumulated in leaf laticifer cell as 
leaf expands. Values are the mean of three measurements (± SEM). 
Abbreviation, LLC : Leaf laticifer cell, LPLC : Leaf primordium laticifer cell, LC : 
Stem laticifer cell.   
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Fig. 28. TIA metabolism in C. roseus stem and leaf tissues. TIA biosynthesis is 
regulated complicatedly. 
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